Companies:
10,795
total market cap:
$142.643 T
Sign In
๐บ๐ธ
EN
English
$ USD
โฌ
EUR
๐ช๐บ
โน
INR
๐ฎ๐ณ
ยฃ
GBP
๐ฌ๐ง
$
CAD
๐จ๐ฆ
$
AUD
๐ฆ๐บ
$
NZD
๐ณ๐ฟ
$
HKD
๐ญ๐ฐ
$
SGD
๐ธ๐ฌ
Global ranking
Ranking by countries
America
๐บ๐ธ United States
๐จ๐ฆ Canada
๐ฒ๐ฝ Mexico
๐ง๐ท Brazil
๐จ๐ฑ Chile
Europe
๐ช๐บ European Union
๐ฉ๐ช Germany
๐ฌ๐ง United Kingdom
๐ซ๐ท France
๐ช๐ธ Spain
๐ณ๐ฑ Netherlands
๐ธ๐ช Sweden
๐ฎ๐น Italy
๐จ๐ญ Switzerland
๐ต๐ฑ Poland
๐ซ๐ฎ Finland
Asia
๐จ๐ณ China
๐ฏ๐ต Japan
๐ฐ๐ท South Korea
๐ญ๐ฐ Hong Kong
๐ธ๐ฌ Singapore
๐ฎ๐ฉ Indonesia
๐ฎ๐ณ India
๐ฒ๐พ Malaysia
๐น๐ผ Taiwan
๐น๐ญ Thailand
๐ป๐ณ Vietnam
Others
๐ฆ๐บ Australia
๐ณ๐ฟ New Zealand
๐ฎ๐ฑ Israel
๐ธ๐ฆ Saudi Arabia
๐น๐ท Turkey
๐ท๐บ Russia
๐ฟ๐ฆ South Africa
>> All Countries
Ranking by categories
๐ All assets by Market Cap
๐ Automakers
โ๏ธ Airlines
๐ซ Airports
โ๏ธ Aircraft manufacturers
๐ฆ Banks
๐จ Hotels
๐ Pharmaceuticals
๐ E-Commerce
โ๏ธ Healthcare
๐ฆ Courier services
๐ฐ Media/Press
๐ท Alcoholic beverages
๐ฅค Beverages
๐ Clothing
โ๏ธ Mining
๐ Railways
๐ฆ Insurance
๐ Real estate
โ Ports
๐ผ Professional services
๐ด Food
๐ Restaurant chains
โ๐ป Software
๐ Semiconductors
๐ฌ Tobacco
๐ณ Financial services
๐ข Oil&Gas
๐ Electricity
๐งช Chemicals
๐ฐ Investment
๐ก Telecommunication
๐๏ธ Retail
๐ฅ๏ธ Internet
๐ Construction
๐ฎ Video Game
๐ป Tech
๐ฆพ AI
>> All Categories
ETFs
๐ All ETFs
๐๏ธ Bond ETFs
๏ผ Dividend ETFs
โฟ Bitcoin ETFs
โข Ethereum ETFs
๐ช Crypto Currency ETFs
๐ฅ Gold ETFs & ETCs
๐ฅ Silver ETFs & ETCs
๐ข๏ธ Oil ETFs & ETCs
๐ฝ Commodities ETFs & ETNs
๐ Emerging Markets ETFs
๐ Small-Cap ETFs
๐ Low volatility ETFs
๐ Inverse/Bear ETFs
โฌ๏ธ Leveraged ETFs
๐ Global/World ETFs
๐บ๐ธ USA ETFs
๐บ๐ธ S&P 500 ETFs
๐บ๐ธ Dow Jones ETFs
๐ช๐บ Europe ETFs
๐จ๐ณ China ETFs
๐ฏ๐ต Japan ETFs
๐ฎ๐ณ India ETFs
๐ฌ๐ง UK ETFs
๐ฉ๐ช Germany ETFs
๐ซ๐ท France ETFs
โ๏ธ Mining ETFs
โ๏ธ Gold Mining ETFs
โ๏ธ Silver Mining ETFs
๐งฌ Biotech ETFs
๐ฉโ๐ป Tech ETFs
๐ Real Estate ETFs
โ๏ธ Healthcare ETFs
โก Energy ETFs
๐ Renewable Energy ETFs
๐ก๏ธ Insurance ETFs
๐ฐ Water ETFs
๐ด Food & Beverage ETFs
๐ฑ Socially Responsible ETFs
๐ฃ๏ธ Infrastructure ETFs
๐ก Innovation ETFs
๐ Semiconductors ETFs
๐ Aerospace & Defense ETFs
๐ Cybersecurity ETFs
๐ฆพ Artificial Intelligence ETFs
Watchlist
Account
Cal-Maine Foods
CALM
#3707
Rank
$3.66 B
Marketcap
๐บ๐ธ
United States
Country
$77.28
Share price
-0.64%
Change (1 day)
-14.21%
Change (1 year)
๐ด Food
๐ Agriculture
Categories
Market cap
Revenue
Earnings
Price history
P/E ratio
P/S ratio
More
Price history
P/E ratio
P/S ratio
P/B ratio
Operating margin
EPS
Stock Splits
Dividends
Dividend yield
Shares outstanding
Fails to deliver
Cost to borrow
Total assets
Total liabilities
Total debt
Cash on Hand
Net Assets
Annual Reports (10-K)
Cal-Maine Foods
Quarterly Reports (10-Q)
Financial Year FY2021 Q3
Cal-Maine Foods - 10-Q quarterly report FY2021 Q3
Text size:
Small
Medium
Large
2021
Q3
false
0000016160
--05-29
4800000
70261000
4800000
120000000
0.01
4800000
0.01
0.01
false
120000000
70261000
4800000
26205000
26287000
0000016160
2020-05-31
2021-02-27
0000016160
2021-02-27
0000016160
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-11-28
0000016160
calm:CommonStockNonConvertibleMember
2020-05-30
0000016160
us-gaap:TreasuryStockMember
2019-06-02
2020-02-29
0000016160
us-gaap:FairValueInputsLevel3Member
2021-02-27
0000016160
srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember
2020-05-30
0000016160
us-gaap:MunicipalBondsMember
calm:NoncurrentAssetsMember
2020-05-30
0000016160
us-gaap:CertificatesOfDepositMember
calm:CurrentAssetsMember
2020-05-30
0000016160
us-gaap:CorporateDebtSecuritiesMember
calm:CurrentAssetsMember
2021-02-27
0000016160
2020-05-30
0000016160
2019-06-02
2020-02-29
0000016160
us-gaap:CorporateDebtSecuritiesMember
calm:CurrentAssetsMember
2020-05-30
0000016160
2019-11-30
0000016160
2019-12-01
2020-02-29
0000016160
us-gaap:NoncontrollingInterestMember
2019-06-02
2020-02-29
0000016160
us-gaap:CommonClassAMember
2020-05-30
0000016160
us-gaap:MunicipalBondsMember
2020-05-30
0000016160
us-gaap:AdditionalPaidInCapitalMember
2020-05-31
2021-02-27
0000016160
us-gaap:AvailableforsaleSecuritiesMember
2019-06-02
2020-02-29
0000016160
us-gaap:TreasuryStockMember
2020-05-30
0000016160
calm:NoncurrentAssetsMember
2021-02-27
0000016160
us-gaap:FairValueInputsLevel2Member
2021-02-27
0000016160
us-gaap:AdditionalPaidInCapitalMember
srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember
2020-05-30
0000016160
2019-06-01
0000016160
us-gaap:CertificatesOfDepositMember
calm:CurrentAssetsMember
2021-02-27
0000016160
us-gaap:CommonStockMember
calm:CommonStockNonConvertibleMember
2020-11-28
0000016160
us-gaap:CorporateDebtSecuritiesMember
2021-02-27
0000016160
us-gaap:CertificatesOfDepositMember
us-gaap:FairValueInputsLevel3Member
2020-05-30
0000016160
calm:NonSpecialtyShellEggSalesMember
2019-12-01
2020-02-29
0000016160
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2019-11-30
0000016160
us-gaap:FairValueInputsLevel2Member
us-gaap:CorporateDebtSecuritiesMember
2021-02-27
0000016160
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-05-30
0000016160
2020-11-29
2021-02-27
0000016160
us-gaap:CommercialPaperMember
2021-02-27
0000016160
us-gaap:RetainedEarningsMember
2019-06-02
2020-02-29
0000016160
us-gaap:PendingLitigationMember
calm:BellEtAlVCalMaineFoodsEtAlMember
srt:MaximumMember
2020-04-30
2020-04-30
0000016160
calm:MutualFundsMember
us-gaap:FairValueInputsLevel3Member
2021-02-27
0000016160
us-gaap:CommonStockMember
calm:CommonStockNonConvertibleMember
srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember
2020-05-30
0000016160
calm:SpecialtyShellEggSalesMember
2020-05-31
2021-02-27
0000016160
us-gaap:AvailableforsaleSecuritiesMember
2020-05-31
2021-02-27
0000016160
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-12-01
2020-02-29
0000016160
calm:NoncurrentAssetsMember
2020-05-30
0000016160
calm:CurrentAssetsMember
2020-05-30
0000016160
us-gaap:CommercialPaperMember
us-gaap:FairValueInputsLevel3Member
2021-02-27
0000016160
us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember
2020-08-24
0000016160
calm:MutualFundsMember
2021-02-27
0000016160
us-gaap:AssetBackedSecuritiesMember
us-gaap:FairValueInputsLevel3Member
2021-02-27
0000016160
us-gaap:MunicipalBondsMember
calm:CurrentAssetsMember
2021-02-27
0000016160
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-11-30
0000016160
us-gaap:CommercialPaperMember
us-gaap:FairValueInputsLevel3Member
2020-05-30
0000016160
calm:NoncurrentAssetsMember
2019-06-02
2020-02-29
0000016160
us-gaap:FairValueInputsLevel3Member
us-gaap:CorporateDebtSecuritiesMember
2020-05-30
0000016160
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2021-02-27
0000016160
calm:EggProductsMember
2019-06-02
2020-02-29
0000016160
calm:CurrentAssetsMember
2021-02-27
0000016160
us-gaap:TreasuryStockMember
2019-12-01
2020-02-29
0000016160
us-gaap:RetainedEarningsMember
2021-02-27
0000016160
us-gaap:FairValueInputsLevel2Member
us-gaap:CommercialPaperMember
2020-05-30
0000016160
us-gaap:AssetBackedSecuritiesMember
calm:CurrentAssetsMember
2020-05-30
0000016160
us-gaap:MunicipalBondsMember
calm:CurrentAssetsMember
2020-05-30
0000016160
us-gaap:CommonStockMember
2021-02-27
0000016160
calm:CommonStockNonConvertibleMember
2021-02-27
0000016160
us-gaap:FairValueInputsLevel2Member
calm:MutualFundsMember
2021-02-27
0000016160
us-gaap:AssetBackedSecuritiesMember
calm:CurrentAssetsMember
2021-02-27
0000016160
us-gaap:CommonClassAMember
2021-02-27
0000016160
us-gaap:TreasuryStockMember
2020-11-28
0000016160
us-gaap:TreasuryStockMember
2021-02-27
0000016160
us-gaap:CommercialPaperMember
2020-05-30
0000016160
us-gaap:CommercialPaperMember
calm:CurrentAssetsMember
2021-02-27
0000016160
us-gaap:CommercialPaperMember
calm:CurrentAssetsMember
2020-05-30
0000016160
us-gaap:RetainedEarningsMember
2020-02-29
0000016160
calm:OtherMember
2020-11-29
2021-02-27
0000016160
us-gaap:RetainedEarningsMember
2020-11-29
2021-02-27
0000016160
us-gaap:CommonStockMember
calm:CommonStockNonConvertibleMember
2019-06-01
0000016160
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember
2020-05-30
0000016160
us-gaap:MunicipalBondsMember
calm:NoncurrentAssetsMember
2021-02-27
0000016160
us-gaap:FairValueInputsLevel2Member
us-gaap:CorporateDebtSecuritiesMember
2020-05-30
0000016160
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-06-02
2020-02-29
0000016160
calm:CommonStockNonConvertibleMember
2021-03-29
0000016160
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-02-27
0000016160
us-gaap:TreasuryStockMember
2020-02-29
0000016160
us-gaap:AdditionalPaidInCapitalMember
2021-02-27
0000016160
us-gaap:AssetBackedSecuritiesMember
us-gaap:FairValueInputsLevel1Member
2020-05-30
0000016160
us-gaap:FairValueInputsLevel2Member
us-gaap:AssetBackedSecuritiesMember
2020-05-30
0000016160
us-gaap:CommonStockMember
calm:CommonStockNonConvertibleMember
2020-05-30
0000016160
us-gaap:TreasuryStockMember
2019-06-01
0000016160
calm:StateOfTexasVCalMaineFoodsIncDbaWhartonAndWhartonCountyFoodsLLCMember
us-gaap:PendingLitigationMember
2020-04-23
2020-04-23
0000016160
srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember
2020-05-30
0000016160
calm:SpecialtyShellEggSalesMember
2019-12-01
2020-02-29
0000016160
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2020-11-28
0000016160
us-gaap:NoncontrollingInterestMember
2019-06-01
0000016160
us-gaap:CommonStockMember
calm:CommonStockNonConvertibleMember
2020-02-29
0000016160
us-gaap:FairValueInputsLevel2Member
calm:MutualFundsMember
2020-05-30
0000016160
calm:OtherMember
2019-12-01
2020-02-29
0000016160
2020-02-29
0000016160
calm:SpecialtyShellEggSalesMember
2019-06-02
2020-02-29
0000016160
us-gaap:TreasuryStockMember
2020-05-31
2021-02-27
0000016160
us-gaap:MunicipalBondsMember
2021-02-27
0000016160
us-gaap:RetainedEarningsMember
2020-11-28
0000016160
calm:NonSpecialtyShellEggSalesMember
2020-11-29
2021-02-27
0000016160
us-gaap:FairValueInputsLevel2Member
us-gaap:CertificatesOfDepositMember
2020-05-30
0000016160
us-gaap:MunicipalBondsMember
us-gaap:FairValueInputsLevel3Member
2020-05-30
0000016160
us-gaap:AssetBackedSecuritiesMember
us-gaap:FairValueInputsLevel1Member
2021-02-27
0000016160
us-gaap:FairValueInputsLevel2Member
us-gaap:CommercialPaperMember
2021-02-27
0000016160
us-gaap:MunicipalBondsMember
us-gaap:FairValueInputsLevel1Member
2021-02-27
0000016160
us-gaap:AccumulatedOtherComprehensiveIncomeMember
srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember
2020-05-30
0000016160
calm:NonSpecialtyShellEggSalesMember
2020-05-31
2021-02-27
0000016160
us-gaap:MunicipalBondsMember
us-gaap:FairValueInputsLevel2Member
2021-02-27
0000016160
us-gaap:MunicipalBondsMember
us-gaap:FairValueInputsLevel3Member
2021-02-27
0000016160
us-gaap:FairValueInputsLevel2Member
2020-05-30
0000016160
us-gaap:AvailableforsaleSecuritiesMember
2021-02-27
0000016160
us-gaap:RetainedEarningsMember
2019-06-01
0000016160
us-gaap:AdditionalPaidInCapitalMember
2020-11-29
2021-02-27
0000016160
2017-01-01
2017-12-31
0000016160
us-gaap:FairValueInputsLevel1Member
us-gaap:CommercialPaperMember
2020-05-30
0000016160
calm:OtherMember
2020-05-31
2021-02-27
0000016160
us-gaap:CertificatesOfDepositMember
us-gaap:FairValueInputsLevel1Member
2021-02-27
0000016160
2020-10-02
0000016160
us-gaap:RetainedEarningsMember
2019-12-01
2020-02-29
0000016160
us-gaap:TreasuryStockMember
2019-11-30
0000016160
us-gaap:AssetBackedSecuritiesMember
2021-02-27
0000016160
us-gaap:RetainedEarningsMember
2019-11-30
0000016160
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-11-29
2021-02-27
0000016160
us-gaap:CommonClassAMember
2021-03-29
0000016160
us-gaap:CommonStockMember
calm:CommonStockNonConvertibleMember
2019-11-30
0000016160
us-gaap:AdditionalPaidInCapitalMember
2020-05-30
0000016160
us-gaap:FairValueInputsLevel3Member
2020-05-30
0000016160
us-gaap:FairValueInputsLevel1Member
us-gaap:CorporateDebtSecuritiesMember
2021-02-27
0000016160
us-gaap:AdditionalPaidInCapitalMember
2020-02-29
0000016160
calm:MutualFundsMember
2020-05-30
0000016160
us-gaap:PendingLitigationMember
calm:BellEtAlVCalMaineFoodsEtAlMember
srt:MinimumMember
2020-04-30
2020-04-30
0000016160
us-gaap:FairValueInputsLevel1Member
2020-05-30
0000016160
calm:NoncurrentAssetsMember
2020-05-31
2021-02-27
0000016160
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2020-05-30
0000016160
us-gaap:AdditionalPaidInCapitalMember
2020-11-28
0000016160
us-gaap:RetainedEarningsMember
srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember
2020-05-30
0000016160
us-gaap:FairValueInputsLevel3Member
us-gaap:CorporateDebtSecuritiesMember
2021-02-27
0000016160
us-gaap:NoncontrollingInterestMember
2020-02-29
0000016160
us-gaap:MunicipalBondsMember
us-gaap:FairValueInputsLevel2Member
2020-05-30
0000016160
us-gaap:FairValueInputsLevel1Member
calm:MutualFundsMember
2021-02-27
0000016160
calm:EggProductsMember
2019-12-01
2020-02-29
0000016160
calm:EggProductsMember
2020-11-29
2021-02-27
0000016160
us-gaap:FairValueInputsLevel1Member
us-gaap:CommercialPaperMember
2021-02-27
0000016160
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2019-06-01
0000016160
us-gaap:RetainedEarningsMember
2020-05-30
0000016160
us-gaap:TreasuryStockMember
srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember
2020-05-30
0000016160
us-gaap:AdditionalPaidInCapitalMember
2019-06-02
2020-02-29
0000016160
us-gaap:AdditionalPaidInCapitalMember
2019-12-01
2020-02-29
0000016160
calm:OtherMember
2019-06-02
2020-02-29
0000016160
2020-11-28
0000016160
us-gaap:RetainedEarningsMember
srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember
2020-05-30
0000016160
calm:MutualFundsMember
us-gaap:FairValueInputsLevel3Member
2020-05-30
0000016160
us-gaap:MunicipalBondsMember
us-gaap:FairValueInputsLevel1Member
2020-05-30
0000016160
calm:SpecialtyShellEggSalesMember
2020-11-29
2021-02-27
0000016160
us-gaap:FairValueInputsLevel2Member
us-gaap:CertificatesOfDepositMember
2021-02-27
0000016160
us-gaap:CertificatesOfDepositMember
us-gaap:FairValueInputsLevel1Member
2020-05-30
0000016160
us-gaap:CertificatesOfDepositMember
us-gaap:FairValueInputsLevel3Member
2021-02-27
0000016160
us-gaap:TreasuryStockMember
2020-11-29
2021-02-27
0000016160
us-gaap:AssetBackedSecuritiesMember
2020-05-30
0000016160
calm:NonSpecialtyShellEggSalesMember
2019-06-02
2020-02-29
0000016160
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-05-31
2021-02-27
0000016160
us-gaap:CommonStockMember
calm:CommonStockNonConvertibleMember
2021-02-27
0000016160
us-gaap:RetainedEarningsMember
2020-05-31
2021-02-27
0000016160
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2020-02-29
0000016160
us-gaap:CorporateDebtSecuritiesMember
2020-05-30
0000016160
calm:EggProductsMember
2020-05-31
2021-02-27
0000016160
us-gaap:CertificatesOfDepositMember
2020-05-30
0000016160
us-gaap:CertificatesOfDepositMember
2021-02-27
0000016160
us-gaap:AdditionalPaidInCapitalMember
2019-11-30
0000016160
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-06-01
0000016160
us-gaap:AdditionalPaidInCapitalMember
2019-06-01
0000016160
us-gaap:NoncontrollingInterestMember
2019-11-30
0000016160
us-gaap:FairValueInputsLevel1Member
us-gaap:CorporateDebtSecuritiesMember
2020-05-30
0000016160
us-gaap:FairValueInputsLevel2Member
us-gaap:AssetBackedSecuritiesMember
2021-02-27
0000016160
us-gaap:FairValueInputsLevel1Member
2021-02-27
0000016160
us-gaap:AvailableforsaleSecuritiesMember
2020-05-30
0000016160
us-gaap:FairValueInputsLevel1Member
calm:MutualFundsMember
2020-05-30
0000016160
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-02-29
0000016160
us-gaap:AssetBackedSecuritiesMember
us-gaap:FairValueInputsLevel3Member
2020-05-30
0000016160
us-gaap:NoncontrollingInterestMember
2019-12-01
2020-02-29
iso4217:USD
xbrli:pure
xbrli:shares
iso4217:USD
xbrli:shares
dummy:Layers
dummy:Pellets
Index
1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
DC
20549
FORM
10-Q
☑
Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934
For the quarterly period ended
February 27, 2021
or
☐
Transition report
pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from ____________ to ____________
Commission File Number:
000-38695
CAL-MAINE FOODS, INC
.
(Exact name of registrant as specified in its charter)
Delaware
64-0500378
(State or other jurisdiction of incorporation or organization)
(I.R.S Employer Identification No.)
3320 Woodrow Wilson Avenue
,
Jackson
,
Mississippi
39209
(Address of principal executive offices)
(Zip Code)
(
601
)
948-6813
(Registrant’s telephone number,
including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.01 par value per share
CALM
The
NASDAQ
Global Select Market
Indicate
by
check
mark
whether
the
registrant:
(1)
has
filed
all
reports
required
to
be
filed
by
Section
13
or
15(d)
of
the
Securities Exchange
Act of 1934
during the preceding
12 months (or
for such
shorter period that
the registrant was
required to
file such reports), and (2) has been subject to such filing requirements for the past
90 days.
Yes
☑
No
☐
Indicate by check
mark whether the
registrant has submitted
electronically every
Interactive Data File
required to be
submitted
pursuant to
Rule 405
of Regulation
S-T (§232.405
of this
chapter) during
the preceding
12 months
(or for
such shorter
period
tha
t the registrant was required to submit such files).
Yes
☑
No
☐
Indicate by
check mark
whether the registrant
is a large
accelerated filer,
an accelerated
filer, a
non-accelerated filer,
a smaller
reporting
company,
or
an
emerging
growth
company.
See
the
definitions
of
“large
accelerated
filer,”
“accelerated
filer”,
“smaller reporting company”, and “emerging growth
company” in Rule 12b-2 of the Exchange Act.
Large Accelerated filer
☑
Accelerated filer
☐
Non – Accelerated filer
☐
Smaller reporting company
☐
Emerging growth company
☐
If
an
emerging
growth
company,
indicate
by
check
mark
if
the
registrant
has
elected
not
to
use
the
extended
transition
period
for
complying
with
any
new
or
revised
financial
accounting
standards
provided
pursuant
to
Section 13(a) of the Exchange Act
☐
Indicate by check mark whether the registrant is a shell company (as defined
in Rule 12b-2 of the Exchange Act).
Yes
☐
No
☑
There were
44,056,163
shares of
Common Stock,
$0.01 par value,
and
4,800,000
shares of Class
A Common
Stock, $0.01
par
value, outstanding as of March 29, 2021.
Index
2
INDEX
Page
Number
Part I.
Financial Information
Item 1.
Condensed Consolidated Financial Statements (Unaudited)
Condensed Consolidated Balance Sheets -
February 27,
2021 and May 30, 2020
3
Condensed Consolidated Statements of Operations -
Thirteen and Thirty-nine Weeks
Ended February 27,
2021 and February 29, 20
20
4
Condensed Consolidated Statements of Comprehensive Income (Loss)
-
Thirteen and Thirty-nine Weeks
Ended February 27, 2021 and February 29, 2020
5
Condensed Consolidated Statements of Cash Flows -
Thirty-nine Weeks
Ended February 27, 2021 and February 29, 2020
6
Notes to Condensed Consolidated Financial Statements
7
Item 2.
Management’s Discussion and Analysis
of
Financial Condition and Results of Operations
20
Item 4.
Controls and Procedures
29
Part II.
Other Information
Item 1.
Legal Proceedings
30
Item 1A.
Risk Factors
29
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
30
Item 6.
Exhibits
31
Signatures
31
Index
3
PART
I.
FINANCIAL
INFORMATION
ITEM 1.
FINANCIAL STATEMENTS
Cal-Maine Foods, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(in thousands, except for par value amounts)
February 27, 2021
43981
Assets
Current assets:
Cash and cash equivalents
$
52,917
$
78,130
Investment securities available-for-sale
127,771
154,163
Trade and other receivables, net
130,314
98,375
Inventories
207,739
187,216
Prepaid expenses and other current assets
4,162
4,367
Total current
assets
522,903
522,251
Property, plant &
equipment, net
585,389
557,375
Finance lease right-of-use asset, net
563
678
Operating lease right-of-use asset, net
1,922
2,531
Investments in unconsolidated entities
57,055
60,982
Goodwill
35,525
35,525
Intangible assets, net
22,256
22,816
Other long-term assets
5,671
4,536
Total Assets
$
1,231,284
$
1,206,694
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable and accrued expenses
$
99,851
$
92,182
Current portion of finance lease obligation
212
205
Current portion of operating lease obligation
741
796
Total current
liabilities
100,804
93,183
Long-term finance lease obligation
492
652
Long-term operating lease obligation
1,180
1,735
Other noncurrent liabilities
9,690
8,681
Deferred income taxes
102,669
92,768
Total liabilities
214,835
197,019
Commitments and contingencies - see
Note 12
—
—
Stockholders’ equity:
Common stock ($
0.01
par value):
Common stock - authorized
120,000
shares, issued
70,261
shares
703
703
Class A convertible common stock - authorized and issued
4,800
shares
48
48
Paid-in capital
63,170
60,372
Retained earnings
980,212
975,147
Accumulated other comprehensive income (loss), net of tax
(
135
)
79
Common stock in treasury at cost –
26,205
shares at February 27, 2021 and
26,287
shares at May 30, 2020
(
27,549
)
(
26,674
)
Total stockholders’
equity
1,016,449
1,009,675
Total Liabilities and
Stockholders’ Equity
$
1,231,284
$
1,206,694
See Notes to Condensed Consolidated Financial Statements.
Index
4
Cal-Maine Foods, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations
(in thousands, except per share amounts)
(unaudited)
Thirteen Weeks
Ended
Thirty-nine Weeks
Ended
February 27, 2021
February 29, 2020
February 27, 2021
February 29, 2020
Net sales
$
359,080
$
345,588
$
999,189
$
898,276
Cost of sales
311,563
295,760
876,457
840,198
Gross profit
47,517
49,828
122,732
58,078
Selling, general and administrative
47,656
44,231
135,494
132,434
Loss on disposal of fixed assets
354
385
476
467
Operating income (loss)
(
493
)
5,212
(
13,238
)
(
74,823
)
Other income (expense):
Interest income, net
591
803
2,181
3,628
Royalty income
321
414
906
1,173
Patronage dividends
9,004
10,096
9,004
10,096
Equity income of unconsolidated entities
1,872
1,445
1,886
537
Other, net
537
79
1,485
1,897
Total other income,
net
12,325
12,837
15,462
17,331
Income (loss) before income taxes
11,832
18,049
2,224
(
57,492
)
Income tax (benefit) expense
(
1,716
)
4,278
(
4,080
)
(
15,356
)
Net income (loss)
13,548
13,771
6,304
(
42,136
)
Less: Income (loss) attributable to noncontrolling
interest
—
22
—
(
64
)
Net income (loss) attributable to Cal-Maine
Foods, Inc.
$
13,548
$
13,749
$
6,304
$
(
42,072
)
Net income (loss) per common share attributable
to Cal-Maine Foods, Inc.:
Basic
$
0.28
$
0.28
$
0.13
$
(
0.87
)
Diluted
$
0.28
$
0.28
$
0.13
$
(
0.87
)
Weighted average
shares outstanding:
Basic
48,530
48,473
48,511
48,455
Diluted
48,659
48,588
48,649
48,455
See Notes to Condensed Consolidated Financial Statements.
Index
5
Cal-Maine Foods, Inc. and Subsidiaries
Condensed Consolidated Statements of
Comprehensive Income (Loss)
(in thousands)
(unaudited)
Thirteen Weeks
Ended
Thirty-nine Weeks
Ended
February 27, 2021
February 29, 2020
February 27, 2021
February 29, 2020
Net profit (loss)
$
13,548
$
13,771
$
6,304
$
(
42,136
)
Other comprehensive income (loss), before tax:
Unrealized holding loss on available-for-sale
securities, net of reclassification adjustments
(
378
)
(
38
)
(
283
)
(
863
)
Income tax benefit related to items of other
comprehensive income
92
9
69
210
Other comprehensive loss, net of tax
(
286
)
(
29
)
(
214
)
(
653
)
Comprehensive income (loss)
13,262
13,742
6,090
(
42,789
)
Less: Comprehensive income (loss) attributable
to the noncontrolling interest
—
22
—
(
64
)
Comprehensive income (loss) attributable to Cal-
Maine Foods, Inc.
$
13,262
$
13,720
$
6,090
$
(
42,725
)
See Notes to Condensed Consolidated Financial Statements.
Index
6
Cal-Maine Foods, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(in thousands)
(unaudited)
Thirty-nine Weeks
Ended
February 27, 2021
February 29, 2020
Operating activities:
Net income (loss)
$
6,304
$
(
42,136
)
Depreciation and amortization
44,391
42,911
Deferred income taxes
9,970
(
13,406
)
Impairment loss on property,
plant & equipment
—
2,919
Other adjustments, net
(
45,936
)
(
26,742
)
Net cash provided by (used in) operations
14,729
(
36,454
)
Investing activities:
Purchases of investment securities
(
59,415
)
(
12,100
)
Sales and maturities of investment securities
85,202
181,533
Distributions from unconsolidated entities
5,813
6,114
Acquisition of business
—
(
44,515
)
Purchases of property,
plant and equipment
(
73,796
)
(
94,600
)
Net proceeds from disposal of property,
plant and equipment
3,273
1,839
Net cash provided by (used in) investing activities
(
38,923
)
38,271
Financing activities:
Purchase of common stock by treasury
(
871
)
(
910
)
Distributions to noncontrolling interests
—
(
755
)
Principal payments on long-term debt
—
(
1,500
)
Principal payments on finance lease
(
153
)
(
146
)
Contributions
5
—
Net cash used in financing activities
(
1,019
)
(
3,311
)
Net change in cash and cash equivalents
(
25,213
)
(
1,494
)
Cash and cash equivalents at beginning of period
78,130
69,247
Cash and cash equivalents at end of period
$
52,917
$
67,753
Supplemental Information:
Cash paid for operating leases
$
703
$
635
Interest paid
$
193
$
77
See Notes to Condensed Consolidated Financial Statements.
Index
7
Cal-Maine Foods, Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
February 27, 2021
(unaudited)
Note 1 - Summary of Significant Accounting Policies
Basis of Presentation
The
unaudited
condensed
consolidated
financial
statements
of
Cal-Maine
Foods,
Inc.
and
its
subsidiaries
(the
"Company,"
"we,"
"us,"
"our")
have
been
prepared
in
accordance
with
the
instructions
to
Form
10-Q
and
Article
10
of
Regulation
S-X.
Therefore, they
do not
include all of
the information
and footnotes
required by
generally accepted
accounting principles
in the
United
States
of
America
("GAAP")
for
complete
financial
statements
and
should
be
read
in
conjunction
with
our
Annual
Report
on
Form
10-K
for
the
fiscal
year
ended
May
30,
2020
(the
"2020
Annual
Report").
These
statements
reflect
all
adjustments that are, in
the opinion of management, necessary
to a fair statement of
the results for the interim
periods presented
and,
in
the
opinion
of
management,
consist
of
adjustments
of
a
normal
recurring
nature.
Operating
results
for
the
interim
periods are not necessarily indicative of operating results for the entire fiscal
year.
Fiscal Year
The Company's
fiscal year
ends on
the Saturday
closest to
May 31.
Each of
the three-month
periods and
year-to-date periods
ended on February 27, 2021 and February 29, 2020 included 13 weeks
and 39 weeks, respectively.
Use of Estimates
The preparation of the
consolidated financial statements in
conformity with GAAP requires management
to make estimates and
assumptions
that affect
the amounts
reported in
the consolidated
financial statements
and accompanying
notes. Actual
results
could differ from those estimates.
The severity,
magnitude and duration, as well as
the economic consequences of the COVID-19
pandemic, are uncertain, rapidly
changing
and
difficult
to
predict.
Therefore,
our
accounting
estimates
and
assumptions
might
change
materially
in
future
periods in response to COVID-19.
Investment Securities
Our investment
securities are
accounted
for in
accordance with
ASC 320,
“Investments -
Debt and
Equity Securities”
(“ASC
320”).
The
Company
considers
all
its
debt
securities
for
which
there
is
a
determinable
fair
market
value,
and
there
are
no
restrictions
on
the
Company's
ability
to
sell
within
the
next
12
months,
as
available-for-sale.
We
classify
these
securities
as
current, because the
amounts invested are available
for current operations.
Available-for-sale
securities are carried at
fair value,
with unrealized
gains and
losses reported
as a
separate
component
of stockholders’
equity.
The Company
regularly
evaluates
changes to
the rating of
its debt securities
by credit
agencies and economic
conditions to assess
and record
any expected
credit
losses through allowance
for credit losses limited
to the amount
that fair value
was less than the
amortized cost basis.
The cost
basis for realized gains and
losses on available-for-sale securities is
determined by the specific identification
method. Gains and
losses
are
recognized
in
other
income
(expenses)
as
Other,
net
in
the
Company's
Condensed
Consolidated
Statements
of
Operations.
Investments
in
mutual
funds
are
classified
as
“Other
long-term
assets”
in
the
Company’s
Consolidated
Balance
Sheets.
Trade Receivables
Trade
receivables are
stated at
their carrying
values, which
include a
reserve for
credit losses.
At February
27, 2021
and May
30,
2020,
reserves
for
credit
losses
were
$
728
thousand
and
$
744
thousand,
respectively.
The
Company
extends
credit
to
customers based on
an evaluation of
each customer's financial
condition and credit
history.
Collateral is generally
not required.
The
Company
minimizes
exposure
to
counter
party
credit
risk
through
credit
analysis
and
approvals,
credit
limits,
and
monitoring
procedures.
In
determining
our
reserve
for
credit losses,
receivables
are
pooled
according
to
age,
with
each
pool
assigned
an
expected
loss
based
on
historical
loss
information
adjusted
as
needed
for
economic
and
other
forward-looking
factors.
Index
8
Change in Accounting Principle
Effective
May
31,
2020,
the
Company
adopted
ASU
2016-13,
Financial
Instruments
–
Credit
Losses
(Topic
326),
which
is
intended
to
improve
financial
reporting
by
requiring
more
timely
recording
of
credit
losses
on
loans
and
other
financial
instruments held by financial institutions and other organizations.
The guidance replaces the prior “incurred loss” approach with
an “expected
loss” model
and requires
measurement of
all expected
credit losses
for financial
assets held
at the
reporting date
based
on
historical
experience,
current
conditions,
and
reasonable
and
supportable
forecasts.
The
Company
adopted
the
guidance on
a modified
retrospective basis
through a
cumulative effect
adjustment to
retained earnings
as of
the beginning
of
the period of
adoption. The Company
evaluated its current
methodology of
estimating allowance for
doubtful accounts and
the
risk
profile
of
its
receivables
portfolio
and
developed
a
model
that
includes
the
qualitative
and
forecasting
aspects
of
the
“expected
loss”
model
under
the
amended
guidance.
The
Company
finalized
its
assessment
of
the
impact
of
the
amended
guidance and recorded a $
422
thousand cumulative increase to retained earnings at May 31, 2020.
Note 2 - Investment
Securities
The following represents the Company’s
investment securities as of February 27, 2021 and May 30, 2020 (in
thousands):
February 27, 2021
Amortized
Cost
Unrealized
Gains
Unrealized
Losses
Estimated
Fair Value
Municipal bonds
$
16,157
$
52
$
—
$
16,209
Commercial paper
6,345
—
—
6,345
Corporate bonds
92,256
1,062
—
93,318
Certificates of deposits
2,084
—
7
2,077
Asset backed securities
9,823
—
1
9,822
Total current
investment securities
$
126,665
$
1,114
$
8
$
127,771
Mutual funds
$
2,293
$
1,424
$
—
$
3,717
Total noncurrent
investment securities
$
2,293
$
1,424
$
—
$
3,717
43981
Amortized
Cost
Unrealized
Gains
Unrealized
Losses
Estimated
Fair Value
Municipal bonds
$
16,093
$
86
$
—
$
16,179
Commercial paper
6,965
17
—
6,982
Corporate bonds
125,594
1,274
—
126,868
Certificates of deposits
1,492
—
—
1,492
Asset backed securities
2,629
13
—
2,642
Total current
investment securities
$
152,773
$
1,390
$
—
$
154,163
Mutual funds
$
2,005
$
744
$
—
$
2,749
Total noncurrent
investment securities
$
2,005
$
744
$
—
$
2,749
Available-for-sale
Proceeds from sales
and maturities of investment
securities available-for-sale
were $
85.2
million and $
181.5
million during the
thirty-nine weeks
ended February 27,
2021 and
February 29,
2020,
respectively.
Gross realized
gains for
the thirty-nine
weeks
ended
February
27,
2021
and
February
29,
2020
were
$
116
thousand
and
$
246
thousand,
respectively.
There
were
$
17
thousand
and
$
7
thousand
gross
realized
losses
for
the
thirty-nine
weeks
ended February
27,
2021
and
February
29,
2020,
respectively.
There were
no
allowance for credit losses at February 27, 2021 and May 30, 2020.
Index
9
Actual maturities
may differ
from contractual
maturities as some
borrowers have
the right to
call or prepay
obligations with
or
without penalties.
Contractual maturities of current investments at February 27, 2021 are
as follows (in thousands):
Estimated Fair Value
Within one year
$
44,862
1-5 years
82,909
Total
$
127,771
Noncurrent
There were
no
sales of
noncurrent investment
securities during
the thirty-nine
weeks ended February
27, 2021.
Proceeds from
sales
and
maturities
of
noncurrent
investment
securities
were
$
1.2
million
during
the
thirty-nine
weeks
ended February
29,
2020.
Gross
realized
gains
for
the
thirty-nine
weeks
ended February
29,
2020
were
$
611
thousand.
There
were
no
realized
losses for the thirty-nine weeks ended February 27, 2021 and February
29, 2020.
Note 3 - Fair Value
Measurements
The Company
is required
to categorize
both financial
and nonfinancial
assets and
liabilities based
on the
following fair
value
hierarchy.
The fair
value of
an asset
is the
price at
which the
asset could
be sold
in an
orderly transaction
between unrelated,
knowledgeable, and willing
parties able to engage in
the transaction. A liability’s
fair value is defined
as the amount that would
be
paid
to
transfer
the
liability
to
a
new
obligor
in
a
transaction
between
such
parties,
not
the
amount
that
would
be paid
to
settle the liability with the creditor.
•
Level 1
- Quoted prices in active markets for identical assets or liabilities
•
Level 2
- Inputs
other than
quoted
prices included
in Level
1 that
are observable
for the
asset or
liability,
either
directly or indirectly,
including:
◦
Quoted prices for similar assets or liabilities in active markets
◦
Quoted prices for identical or similar assets in non-active markets
◦
Inputs other than quoted prices that are observable for the asset or liability
◦
Inputs derived principally from or corroborated by other observable
market data
•
Level 3
- Unobservable inputs for the asset or liability that are
supported by little or no market activity and that
are
significant to the fair value of the assets or liabilities
The disclosures of fair value of certain financial assets and liabilities that are recorded
at cost are as follows:
Cash and cash equivalents, accounts receivable,
and accounts payable:
The carrying amount approximates fair value due to the
short maturity of these instruments.
Lease obligations:
The carrying value of the Company’s lease obligations
is at its present value which approximates fair value.
Assets and Liabilities Measured at Fair
Value
on a Recurring Basis
In
accordance
with
the
fair
value
hierarchy
described
above,
the
following
table
shows
the
fair
value
of
financial
assets and
liabilities measured at fair value on a recurring basis as of February 27, 2021 and May 30,
2020 (in thousands):
February 27, 2021
Level 1
Level 2
Level 3
Balance
Assets
Municipal bonds
$
—
$
16,209
$
—
$
16,209
Commercial paper
—
6,345
—
6,345
Corporate bonds
—
93,318
—
93,318
Certificates of deposits
—
2,077
—
2,077
Asset backed securities
—
9,822
—
9,822
Mutual funds
3,717
—
—
3,717
Total assets measured at fair
value
$
3,717
$
127,771
$
—
$
131,488
Index
10
43981
Level 1
Level 2
Level 3
Balance
Assets
Municipal bonds
$
—
$
16,179
$
—
$
16,179
Commercial paper
—
6,982
—
6,982
Corporate bonds
—
126,868
—
126,868
Certificates of deposits
—
1,492
—
1,492
Asset backed securities
—
2,642
—
2,642
Mutual funds
2,749
—
—
2,749
Total assets measured at fair
value
$
2,749
$
154,163
$
—
$
156,912
Investment
securities
–
available-for-sale
classified
as Level
2
consist
of
securities
with maturities
of
three
months
or longer
when purchased. Observable inputs for these securities are yields, credit risks, default
rates, and volatility.
Note 4 - Inventories
Inventories consisted of the following as of February 27, 2021 and
May 30, 2020 (in thousands):
February 27, 2021
43981
Flocks, net of amortization
$
115,904
$
110,198
Eggs and egg products
18,069
18,487
Feed and supplies
73,766
58,531
$
207,739
$
187,216
We
grow
and
maintain
flocks
of
layers
(mature
female
chickens),
pullets
(female
chickens,
under
18
weeks
of
age),
and
breeders (male and female chickens used to produce fertile eggs
to hatch for egg production flocks).
Our total flock at February
27, 2021 consisted of approximately
9.6
million pullets and breeders and
41.3
million layers.
Note 5 - Accrued Dividends Payable and Dividends per Common
Share
We
accrue dividends at
the end of
each quarter according
to the Company’s
dividend policy adopted
by its Board
of Directors.
The Company
pays a dividend
to shareholders
of its Common
Stock and
Class A Common
Stock on
a quarterly basis
for each
quarter for
which the
Company reports
net income
attributable to
Cal-Maine Foods,
Inc. computed
in accordance
with GAAP
in an amount
equal to one-third
(1/3) of such
quarterly income. Dividends
are paid to
shareholders of record
as of the 60th
day
following the
last day of
such quarter,
except for the
fourth fiscal quarter.
For the fourth
quarter,
the Company pays
dividends
to shareholders of record on the 65th day after the
quarter end. Dividends are payable on the 15th day following
the record date.
Following a quarter for which the Company does not report net income
attributable to Cal-Maine Foods, Inc., the Company will
not pay a dividend
for a subsequent profitable
quarter until the Company
is profitable on a cumulative
basis computed from the
date
of
the
last
quarter
for
which
a
dividend
was
paid.
For
the
third
quarter
of
fiscal
2021,
we
will
pay
a
cash
dividend
of
approximately
$
0.034
per share
to holders
of our
Common Stock
and
Class A
Common
Stock.
The amount
of the
accrual is
recorded in Accounts payable and accrued expenses in the Company’s
Condensed Consolidated Balance Sheets.
Index
11
On
our
condensed
consolidated
statement
of
operations,
we
determine
dividends
per
common
share
in
accordance
with
the
computation in the following table (in thousands, except per share data):
Thirteen Weeks
Ended
Thirty-nine Weeks
Ended
February 27, 2021
February 29, 2020
February 27, 2021
February 29, 2020
Net income (loss) attributable to Cal-Maine
Foods, Inc.
$
13,548
$
13,749
$
6,304
$
(
42,072
)
Cumulative losses to be recovered prior to
payment of divided at beginning of period
(
8,614
)
(
75,582
)
(
1,370
)
(
19,761
)
Net income attributable to Cal-Maine Foods,
Inc. available for dividend
$
4,934
$
—
$
4,934
$
—
1/3 of net income attributable to Cal-Maine
Foods, Inc. available for dividend
1,645
Common stock outstanding (shares)
44,056
Class A common stock outstanding (shares)
4,800
Total common stock
outstanding (shares)
48,856
Dividends per common share*
$
0.034
*
Dividends per common share
= 1/3 of Net
income (loss) attributable to
Cal-Maine Foods, Inc. available
for dividend ÷ Total
common stock
outstanding (shares).
Note 6 - Equity
The following reflects the equity activity,
for the thirteen and thirty-nine weeks ended February 27,
2021 and February 29, 2020
(in thousands):
Thirteen Weeks Ended February
27, 2021
Cal-Maine Foods, Inc. Stockholders
Common Stock
Class A
Treasury
Paid In
Accum. Other
Retained
Amount
Amount
Amount
Capital
Comp. Income
Earnings
Total
Balance at November 28, 2020
$
703
$
48
$
(
26,723
)
$
62,206
$
151
$
968,325
$
1,004,710
Other comprehensive loss, net of
tax
—
—
—
—
(
286
)
—
(
286
)
Purchase of company stock
—
—
(
826
)
—
—
—
(
826
)
Restricted stock compensation
—
—
—
964
—
—
964
Dividends
—
—
—
—
—
(
1,661
)
(
1,661
)
Net income
—
—
—
—
—
13,548
13,548
Balance at February 27, 2021
$
703
$
48
$
(
27,549
)
$
63,170
$
(
135
)
$
980,212
$
1,016,449
Index
12
Thirteen Weeks Ended February 29, 2020
Cal-Maine Foods, Inc. Stockholders
Common Stock
Class A
Treasury
Paid In
Accum. Other
Retained
Noncontrolling
Amount
Amount
Amount
Capital
Comp. Income
Earnings
Interest
Total
Balance at November 30,
2019
$
703
$
48
$
(
25,888
)
$
58,652
$
(
269
)
$
900,485
$
562
$
934,293
Other comprehensive
loss, net of tax
—
—
—
—
(
29
)
—
—
(
29
)
Restricted stock
forfeitures
—
—
103
(
103
)
—
—
—
—
Purchase of company
stock
—
—
(
889
)
—
—
—
—
(
889
)
Restricted stock
compensation
—
—
—
886
—
—
—
886
Net income
—
—
—
—
—
13,749
22
13,771
Balance at February 29,
2020
$
703
$
48
$
(
26,674
)
$
59,435
$
(
298
)
$
914,234
$
584
$
948,032
Thirty-nine Weeks Ended February
27, 2021
Cal-Maine Foods, Inc. Stockholders
Common Stock
Class A
Treasury
Paid In
Accum. Other
Retained
Amount
Amount
Amount
Capital
Comp. Income
Earnings
Total
Balance at May 30, 2020
$
703
$
48
$
(
26,674
)
$
60,372
$
79
$
975,147
$
1,009,675
Impact of ASC 326, see
Note 1
—
—
—
—
—
422
422
Balance at May 31, 2020
703
48
(
26,674
)
60,372
79
975,569
1,010,097
Other comprehensive loss, net of
tax
—
—
—
—
(
214
)
—
(
214
)
Restricted stock forfeitures
—
—
(
4
)
4
—
—
—
Purchase of company stock
—
—
(
871
)
—
—
—
(
871
)
Restricted stock compensation
—
—
—
2,789
—
—
2,789
Contributions
—
—
—
5
—
—
5
Dividends
—
—
—
—
—
(
1,661
)
(
1,661
)
Net income
—
—
—
—
—
6,304
6,304
Balance at February 27, 2021
$
703
$
48
$
(
27,549
)
$
63,170
$
(
135
)
$
980,212
$
1,016,449
Index
13
Thirty-nine Weeks Ended February 29, 2020
Cal-Maine Foods, Inc. Stockholders
Common Stock
Class A
Treasury
Paid In
Accum. Other
Retained
Noncontrolling
Amount
Amount
Amount
Capital
Comp. Income
Earnings
Interest
Total
Balance at June 01, 2019
$
703
$
48
$
(
25,866
)
$
56,857
$
355
$
954,527
$
3,182
$
989,806
Other comprehensive
loss, net of tax
—
—
—
—
(
653
)
—
—
(
653
)
Restricted stock
forfeitures
—
—
102
(
102
)
—
—
—
—
Purchase of company
stock
—
—
(
910
)
—
—
—
—
(
910
)
Distributions to
noncontrolling interest
partners
—
—
—
—
—
—
(
755
)
(
755
)
Reclass of equity portion
of Texas Egg Products,
LLC in connection with
acquisition
—
—
—
—
—
1,779
(
1,779
)
—
Restricted stock
compensation
—
—
—
2,680
—
—
—
2,680
Net loss
—
—
—
—
—
(
42,072
)
(
64
)
(
42,136
)
Balance at February 29,
2020
$
703
$
48
$
(
26,674
)
$
59,435
$
(
298
)
$
914,234
$
584
$
948,032
Note 7 - Net Income (Loss) per Common Share
Basic net
income (loss)
per share
attributable to
Cal-Maine Foods,
Inc. is
based on
the weighted
average Common
Stock and
Class A Common
Stock outstanding.
Diluted net income
per share attributable
to Cal-Maine Foods,
Inc. is based
on weighted-
average
common
shares
outstanding
during
the
relevant
period
adjusted
for
the
dilutive
effect
of
share-based
awards.
Restricted
shares
of
121
thousand
were
antidilutive
due
to
the
net
loss
for
the
thirty-nine
weeks
ended
February
29,
2020.
These shares were not included in the diluted net loss per share calculation.
Index
14
The
following
table
provides
a
reconciliation
of
the
numerators
and
denominators
used
to
determine
basic
and
diluted
net
income per common share attributable to Cal-Maine Foods, Inc.
(amounts in thousands, except per share data):
Thirteen Weeks
Ended
Thirty-nine Weeks
Ended
February 27, 2021
February 29, 2020
February 27, 2021
February 29, 2020
Numerator
Net income (loss)
$
13,548
$
13,771
$
6,304
$
(
42,136
)
Less: Income (loss) attributable to
noncontrolling interest
—
22
—
(
64
)
Net income (loss) attributable to Cal-
Maine Foods, Inc.
$
13,548
$
13,749
$
6,304
$
(
42,072
)
Denominator
Weighted-average
common shares
outstanding, basic
48,530
48,473
48,511
48,455
Effect of dilutive restricted shares
129
115
138
—
Weighted-average
common shares
outstanding, diluted
48,659
48,588
48,649
48,455
Net income (loss) per common share
attributable to Cal-Maine Foods, Inc.
Basic
$
0.28
$
0.28
$
0.13
$
(
0.87
)
Diluted
$
0.28
$
0.28
$
0.13
$
(
0.87
)
Note 8 - Revenue Recognition
Satisfaction of Performance Obligation
The vast
majority of
the Company’s
revenue is
derived from
contracts with
customers based
on the
customer placing
an order
for products.
Pricing for the most part
is determined when the
Company and the customer
agree upon the specific
order, which
establishes the contract for that order.
Revenues are
recognized in
an amount
that reflects
the net
consideration we
expect to
receive in
exchange for
the goods.
Our
shell eggs
are sold
at prices
related to
independently
quoted wholesale
market prices,
negotiated prices
or formulas
related to
our costs
of production.
The Company’s
sales predominantly
contain a
single performance
obligation.
We
recognize revenue
upon satisfaction
of the performance
obligation with
the customer,
which typically occurs
within days of
the Company
and the
customer agreeing upon the order.
Returns and Refunds
Some of our contracts
include a guaranteed sale
clause, pursuant to which
we credit the customer’s
account for product
that the
customer is unable to
sell before expiration.
The Company records an
estimate of returns and
refunds by using historical return
data and
comparing to
current period
sales and
accounts receivable.
The allowance
is recorded
as a
reduction in
sales with
a
corresponding reduction in trade accounts receivable.
Sales Incentives Provided to Customers
The
Company
periodically
provides
incentive
offers
to
its
customers
to
encourage
purchases.
Such
offers
include
current
discount offers
(e.g., percentage
discounts off
current purchases), inducement
offers (e.g.,
offers for
future discounts subject
to
a minimum
current purchase),
and other
similar offers.
Current discount
offers,
when accepted
by customers,
are treated
as a
reduction
to
the sales
price
of the
related
transaction,
while inducement
offers,
when
accepted
by
customers,
are
treated
as a
reduction to sales price based on estimated future redemption rates.
Index
15
Disaggregation of Revenue
The following table provides revenue disaggregated by product category
(in thousands):
Thirteen Weeks
Ended
Thirty-nine Weeks
Ended
February 27, 2021
February 29, 2020
February 27, 2021
February 29, 2020
Conventional shell egg sales
$
203,189
$
210,329
$
560,297
$
518,898
Specialty shell egg sales
145,210
125,019
408,537
352,118
Egg products
9,098
9,212
25,736
24,210
Other
1,583
1,028
4,619
3,050
$
359,080
$
345,588
$
999,189
$
898,276
Contract Costs
The Company can
incur costs to obtain
or fulfill a contract
with a customer.
The amortization period
of these costs is
less than
one year; therefore, they are expensed as incurred.
Contract Balances
The Company
receives payment
from
customers based
on specified
terms that
are generally
less than
30 days
from
delivery.
There are
rarely contract
assets or
liabilities related
to performance
under the
contract and
they are generally
immaterial to
the
financial statements.
Note 9 - Leases
Expenses related
to operating
leases, amortization
of finance
leases, right-of-use
assets, and
finance lease
interest are
included
in Cost of sales, Selling general and administrative expense, and Interest
income, net in the Condensed Consolidated Statements
of Operations. The Company’s lease cost
consists of the following (in thousands):
13 Weeks Ended
February 27, 2021
39 Weeks Ended
February 27, 2021
Operating Lease cost
$
233
$
703
Finance Lease cost
Amortization of right-of-use asset
$
44
$
125
Interest on lease obligations
$
9
$
27
Short term lease cost
$
857
$
2,714
Index
16
Future minimum lease payments under non-cancelable leases are as follows (in
thousands):
As of February 27, 2021
Operating Leases
Finance Leases
Remainder fiscal 2021
$
224
$
68
2022
802
239
2023
539
239
2024
380
218
2025
130
—
2026
26
—
Thereafter
5
—
Total
2,106
764
Less imputed interest
(
185
)
(
60
)
Total
$
1,921
$
704
The
weighted-average
remaining
lease
term
and
discount
rate
for
lease
liabilities
included
in
our
Condensed
Consolidated
Balance Sheet are as follows:
As of February 27, 2021
Operating Leases
Finance Leases
Weighted-average
remaining lease term (years)
3.0
2.8
Weighted-average
discount rate
5.9
%
4.9
%
Note 10 - Stock Based Compensation
On
October
2,
2020,
shareholders
approved
the
Amended
and
Restated
Cal-Maine
Foods,
Inc.
2012
Omnibus
Long-Term
Incentive
Plan
(the
“Plan”).
The
purpose
of
the
Plan
is
to
assist
us
and
our
subsidiaries
in
attracting
and
retaining
selected
individuals
who
are
expected
to
contribute
to
our
long-term
success.
The
maximum
number
of
shares
of
common
stock
available
for
awards
under
the
Plan
is
2,000,000
,
of
which
1,128,488
shares
remain
available
for
issuance,
and
may
be
authorized but
unissued shares
or treasury
shares. Awards
may be
granted under
the Plan
to any
employee, any
non-employee
member of the Company’s
Board of Directors, and
any consultant who is
a natural person and
provides services to us
or one of
our subsidiaries (except for incentive stock options, which may be granted
only to our employees).
The only
outstanding awards
under the
Plan are
restricted stock
awards. The
restricted stock
vests one
to three
years from
the
grant
date, or
upon death
or disability,
change
in control,
or retirement
(subject to
certain requirements).
The restricted
stock
contains no other service or performance
conditions. Restricted stock is awarded in
the name of the recipient and, except
for the
right of
disposal, constitutes
issued and
outstanding shares
of the
Company’s
common stock
for all
corporate purposes
during
the period
of restriction
including the
right to
receive dividends.
Compensation
expense is
a fixed
amount based
on the
grant
date closing price and is amortized over the vesting period.
Total
stock-based compensation
expense was
$
2.8
million and
$
2.7
million for
the thirty-nine
weeks ended
February 27,
2021
and February 29, 2020, respectively.
Unrecognized
compensation expense
as a
result of
non-vested
shares of
restricted stock
outstanding under
the 2012
Omnibus
Long-Term
Incentive Plan
at February
27, 2021
of $
7.5
million will
be recorded
over a
weighted average
period of
2.3
years.
Refer
to
Note
16
of
our
audited
financial
statements
in
our
2020
Annual
Report
for
further
information
on
our
stock
compensation plans.
Index
17
The Company’s restricted share activity
for the thirty-nine weeks ended February 27, 2021 follows:
Number of
Shares
Weighted
Average Grant
Date Fair Value
Outstanding, May 30, 2020
273,046
$
41.36
Granted
110,560
37.71
Vested
(
79,328
)
43.96
Forfeited
(
4,431
)
40.12
Outstanding, February 27, 2021
299,847
$
39.35
Note 11 – Income Taxes
The differences
between income
tax expense
(benefit)
at the
Company’s
effective
income tax
rate and
income tax
expense at
the statutory federal income tax rate for the thirteen and thirty-nine
weeks ended as of February 27, 2021 were as follows:
Thirteen Weeks
Ended
Thirty-nine Weeks
Ended
February 27, 2021
February 27, 2021
Statutory federal income tax
$
2,907
$
543
Enacted net operating loss carryback provision
(
6,422
)
(
6,422
)
Domestic manufacturers deduction
1,408
1,408
Other, net
391
391
$
(
1,716
)
$
(
4,080
)
On March
27, 2020,
the Coronavirus
Aid, Relief,
and Economic
Security
Act (the
“CARES Act”)
was enacted.
The CARES
Act
contains
several income
tax provisions,
as well
as other
measures,
that are
intended to
assist businesses
impacted
by
the
economic
effects
of
the
COVID-19
pandemic.
The
most
significant
provision
of
the
CARES
Act
that
materially
affects
our
accounting
for
income
taxes
includes
a
five-year
carryback
allowance
for
taxable
net
operating
losses generated
in
tax
years
2018 through 2020, our fiscal years 2019 through 2021.
Our financial
statements for
the thirteen
weeks ended
February 27,
2021 were
affected by
the changes
enacted by
the CARES
Act.
As a result of the applicable accounting
guidance and the provisions enacted by the CARES Act, our
income tax provision
for the
third quarter
of fiscal
2021 reflects
the carryback
of taxable
net operating
losses generated
during periods
in which
the
statutory
federal
income
tax
rate
was
21
%
to
periods
in
which
the
statutory
federal
income
tax
rate
was
35
%.
Due
to
the
difference
in statutory
rates, we
recorded a
$
6.4
million discrete
income tax
benefit related
to the
carryback provisions
during
the thirteen
weeks ended
February 27,
2021. Because
the net
operating losses
were carried
back to
years in
which we
initially
reduced our taxable income using
the Domestic Production Activities Deduction,
we recorded a partially offsetting
$
1.4
million
discrete income tax expense during the thirteen weeks ended February 27,
2021 to account for the reduced taxable income.
Note 12 - Commitments and Contingencies
Financial Instruments
The Company maintained
standby letters of credit
("LOC") totaling $
4.1
million at February 27,
2021 which were issued
under
the Company's Revolving Credit Facility.
The outstanding LOCs are for the benefit of certain insurance
companies, and are not
recorded as a liability on the consolidated balance sheets.
LEGAL PROCEEDINGS
State of Texas
v. Cal-Maine Foods, Inc. d/b/a Wharton;
and Wharton County Foods, LLC
On April
23, 2020,
the Company
and its subsidiary
Wharton County
Foods, LLC (“WCF”)
were named
as defendants in
State
of
Texas
v.
Cal-Maine
Foods,
Inc.
d/b/a
Wharton;
and
Wharton
County
Foods,
LLC,
Cause
No.
2020-25427,
in
the
District
Court of
Harris County,
Texas.
The State
of Texas
(the “State”)
asserted claims
based on
the Company’s
and WCF’s
alleged
violation
of
the
Texas
Deceptive
Trade
Practices—Consumer
Protection
Act,
Tex.
Bus.
&
Com.
Code
§§
17.41-17.63
(“DTPA”).
The
State
claimed
that
the
Company
and
WCF
offered
shell
eggs
at
excessive
or
exorbitant
prices
during
the
COVID-19
state
of
emergency
and
made
misleading
statements
about
shell
egg
prices.
The
State
sought
temporary
and
Index
18
permanent
injunctions
against
the
Company
and
WCF
to
prevent
further
alleged
violations
of
the
DTPA,
along
with
over
$
100,000
in damages. On August 13, 2020, the court granted the defendants’ motion
to dismiss the State’s original petition with
prejudice. On September
11, 2020,
the State filed a
notice of appeal,
which was assigned to
the Texas
Court of Appeals
for the
First District. The
State filed its
opening brief
on December 7,
2020. The
Company and
WCF filed their
response on
February
8, 2021.
Management believes the risk of material loss related to this matter to be remote.
Bell et al. v. Cal-Maine Foods et al.
On
April
30, 2020,
the Company
was named
as one
of several
defendants
in
Bell et
al. v.
Cal-Maine
Foods et
al.,
Case No.
1:20-cv-461,
in
the
Western
District
of
Texas,
Austin
Division.
The
defendants
include
numerous
grocery
stores,
retailers,
producers, and farms. Plaintiffs assert that defendants
violated the DTPA
by allegedly demanding exorbitant or
excessive prices
for
eggs during
the
COVID-19
state of
emergency.
Plaintiffs
request
certification
of a
class of
all consumers
who purchased
eggs
in
Texas
sold,
distributed,
produced,
or
handled
by
any
of
the
defendants
during
the
COVID-19
state
of
emergency.
Plaintiffs seek to enjoin
the Company and other
defendants from selling eggs
at a price more than
10% greater than the price
of
eggs prior
to the
declaration
of the
state of
emergency
and damages
in the
amount
of
$
10,000
per violation,
or $
250,000
for
each violation impacting anyone over
65 years old. On December
1, 2020, the Company and certain
other defendants filed their
motion
to
dismiss
the
plaintiffs’
first
amended
class
action
complaint.
The
court
has
not
ruled
on
this
motion
to
dismiss.
Management believes the risk of material loss related to this matter to be remote.
Kraft Foods Global, Inc. et al. v.
United Egg Producers, Inc. et al.
As previously
reported, on
September 25,
2008, the
Company
was named
as one
of several
defendants
in numerous
antitrust
cases involving
the United
States shell
egg
industry.
The Company
settled all
of these
cases, except
for
the claims
of certain
plaintiffs who sought substantial
damages allegedly arising from
the purchase of egg products
(as opposed to shell eggs).
These
remaining plaintiffs
are Kraft
Food Global,
Inc., General
Mills, Inc.,
and Nestle
USA, Inc.
(the “Egg
Products Plaintiffs”)
and
The Kellogg Company.
On September
13, 2019,
the case
with the
Egg Products
Plaintiffs was
remanded from
a multi-district
litigation proceeding
in
the
United
States
District
Court
for
the
Eastern
District
of
Pennsylvania,
In
re
Processed
Egg
Products
Antitrust
Litigation,
MDL No. 2002, to
the United States District Court
for the Northern
District of Illinois, Kraft Foods
Global, Inc. et al. v.
United
Egg
Producers,
Inc.
et
al.,
Case
No.
1:11-cv-8808,
for
trial.
The
Egg
Products
Plaintiffs
allege
that
the
Company
and
other
defendants
violated
Section
1
of
the
Sherman
Act,
15.
U.S.C.
§
1,
by
agreeing
to
limit
the
production
of
eggs
and
thereby
illegally to raise the prices that plaintiffs
paid for processed egg products. In particular,
the Egg Products Plaintiffs are
attacking
certain features of
the United Egg
Producers animal-welfare guidelines
and program used by
the Company and
many other egg
producers. The
Egg Products
Plaintiffs seek
to enjoin
the Company
and other
defendants from
engaging in
antitrust violations
and seek treble money damages. The parties filed a joint status
report on May 18, 2020, but no schedule has
yet been entered by
the court. It appears that the case will not be tried until later in 2021 or 2022.
In addition,
on October
24, 2019,
the Company
entered into
a confidential
settlement agreement
with The
Kellogg Company
dismissing
all
claims
against
the
Company
for
an
amount
that
did
not
have
a
material
impact
on
the
Company’s
financial
condition or results
of operations. On
November 11,
2019, a stipulation
for dismissal was filed
with the court,
but the court
has
not yet entered a judgment on the filing.
The Company intends to
continue to defend the remaining
case with the Egg Products Plaintiffs
as vigorously as possible based
on
defenses
which
the
Company
believes
are
meritorious
and
provable.
Adjustments,
if
any,
which
might
result
from
the
resolution of
this remaining
matter with
the Egg
Products Plaintiffs
have not
been reflected
in the
financial statements.
While
management
believes
that
there
is
still
a
reasonable
possibility
of
a
material
adverse
outcome
from
the
case
with
the
Egg
Products Plaintiffs,
at the
present time,
it is not
possible to
estimate the
amount of
monetary exposure,
if any,
to the
Company
due to a range of
factors, including the following,
among others: the matter is in
the early stages of
preparing for trial following
remand;
any
trial
will
be
before
a
different
judge
and
jury
in
a
different
court
than
prior
related
cases;
there
are
significant
factual issues
to be
resolved; and
there are
requests for
damages other
than compensatory
damages
(i.e., injunction
and treble
money damages).
State of Oklahoma Watershed Pollution
Litigation
On June
18, 2005,
the State
of Oklahoma
filed suit,
in the
United States
District Court
for the
Northern District
of Oklahoma,
against Cal-Maine Foods, Inc. and
Tyson Foods,
Inc. and affiliates, Cobb-Vantress,
Inc., Cargill, Inc. and its
affiliate, George’s,
Inc. and
its affiliate,
Peterson Farms, Inc.
and Simmons Foods,
Inc. The
State of Oklahoma
claims that through
the disposal of
chicken
litter the
defendants have
polluted the
Illinois River
Watershed.
This watershed
provides
water to
eastern Oklahoma.
Index
19
The complaint
seeks injunctive
relief and
monetary damages,
but the
claim for
monetary damages
has been
dismissed by
the
court.
Cal-Maine
Foods,
Inc.
discontinued
operations
in
the
watershed.
Accordingly,
we
do
not
anticipate
that
Cal-Maine
Foods,
Inc.
will
be
materially
affected
by
the
request
for
injunctive
relief
unless
the
court
orders
substantial
affirmative
remediation. Since
the litigation
began, Cal-Maine
Foods, Inc.
purchased 100%
of the membership
interests of
Benton County
Foods, LLC,
which is
an ongoing
commercial shell
egg operation
within the
Illinois River
Watershed.
Benton County
Foods,
LLC is not a defendant in the litigation.
The trial in the case
began in September 2009 and
concluded in February 2010. The
case was tried without a jury,
and the court
has not yet issued its ruling. Management believes the risk of material loss related
to this matter to be remote.
Other Matters
In addition to
the above, the Company
is involved in
various other claims
and litigation incidental
to its business. Although
the
outcome of
these matters
cannot be
determined with
certainty,
management, upon
the advice
of counsel,
is of
the opinion
that
the final outcome should not have a material effect on the Company’s
consolidated results of operations or financial position.
Note 13 - Related Party Transaction
On
August
24,
2020,
Mrs.
Jean
Reed
Adams,
the
wife
of
the
Company’s
late
founder
Fred
R.
Adams,
Jr.,
and
the
Fred
R.
Adams,
Jr.
Daughters’
Trust,
dated
July
20,
2018
(the
“Daughters’
Trust”),
of
which
the
daughters
of
Mr.
Adams
are
beneficiaries
(together,
the
“Selling
Stockholders”),
completed
a
registered
secondary
public
offering
of
6,900,000
shares
of
Common Stock held by them, pursuant to a previously
disclosed Agreement Regarding Common Stock (the “Agreement”)
filed
as an exhibit to our 2020 Annual Report. Mrs. Adams and
the Daughters’ Trust advised the Company that
they were conducting
the
offering
in
order
to
pay
estate
taxes
related
to
the
settlement
of
Mr.
Adam’s
estate
and
to
obtain
liquidity.
The
public
offering
was
made
pursuant
to
the
Company’s
effective
shelf
registration
statement
on
Form
S-3
(File
No.
333-227742),
including the Prospectus
contained therein dated
October 9, 2018, and
a related Prospectus Supplement
dated August 19,
2020,
each of
which is on
file with the
Securities and
Exchange Commission.
The public offering
involved only
the sale of
shares of
Common
Stock
that
were
already
outstanding,
and
thus
the
Company
did
not
issue
any
new
shares
or
raise
any
additional
capital
in
the
offering.
The
expenses
of
the
offering
(not
including
the
underwriting
discount
and
legal
fees
and
expenses
of
legal
counsel
for
the
Selling
Stockholders,
which
were
paid
by
the
Selling
Stockholders)
paid
by
the
Company
were
$
1,102,000
. Pursuant to the Agreement, the Selling Stockholders reimbursed the Company
$
551,000
.
Index
20
ITEM
2.
MANAGEMENT’S
DISCUSSION
AND
ANALYSIS
OF
FINANCIAL
CONDITION
AND
RESULTS
OF
OPERATIONS
The following
should be
read in
conjunction
with Management’s
Discussion and
Analysis of
Financial Condition
and Results
of Operations
included in
Item 7
of the
Company’s
Annual Report
on Form
10-K for
its fiscal
year ended
May 30,
2020 (the
“2020
Annual Report”),
and
the accompanying
financial statements
and
notes included
in Part
II, Item
8 of
the 2020
Annual
Report and in
Part
I, Item I
of this Quarterly Report on Form 10-Q (“Quarterly Report”).
This
report
contains
numerous
forward-looking
statements
within
the
meaning
of
Section
27A
of
the
Securities
Act
of
1933
(the “Securities
Act”) and
Section 21E
of the
Securities Exchange
Act of
1934 (the
“Exchange Act”)
relating to
our shell
egg
business,
including
estimated
future
production
data,
expected
construction
schedules,
projected
construction
costs,
potential
future
supply
of and
demand
for
our
products,
potential
future
corn
and
soybean price
trends,
potential
future
impact
on
our
business
of
the
COVID-19
pandemic,
potential
future
impact
on
our
business
of
new
legislation,
rules
or
policies,
potential
outcomes
of
legal
proceedings,
and
other
projected
operating
data,
including
anticipated
results
of
operations
and
financial
condition.
Such
forward-looking
statements
are
identified
by
the
use
of
words
such
as
“believes,”
“intends,”
“expects,”
“hopes,”
“may,”
“should,”
“plans,”
“projected,”
“contemplates,”
“anticipates,”
or
similar
words.
Actual
outcomes
or
results
could differ
materially from
those projected
in the
forward-looking
statements.
The forward-looking
statements are
based on
management’s
current
intent,
belief,
expectations,
estimates,
and
projections
regarding
the
Company
and
its
industry.
These
statements
are
not
guarantees
of
future
performance
and
involve
risks,
uncertainties,
assumptions,
and
other
factors
that
are
difficult
to predict
and may
be beyond
our control.
The factors
that could
cause actual
results to
differ
materially from
those
projected
in the
forward-looking
statements include,
among others,
(i) the
risk factors
set forth
in Part
I, Item
1A of
the 2020
Annual
Report
(ii)
the
risks
and
hazards
inherent
in
the
shell egg
business
(including
disease, pests,
weather
conditions,
and
potential for
product recall),
(iii) changes
in the
demand for
and market
prices of
shell eggs
and feed
costs, (iv)
our ability
to
predict
and
meet
demand
for
cage-free
and
other
specialty
eggs,
(v)
risks,
changes,
or
obligations
that
could
result
from
our
future
acquisition
of
new
flocks
or
businesses
and
risks
or
changes
that
may
cause
conditions
to
completing
a
pending
acquisition not to
be met, (vi) risks
relating to the
evolving COVID-19 pandemic,
and (vii) adverse
results in pending litigation
matters.
Readers
are
cautioned
not
to
place
undue
reliance
on
forward-looking
statements
because,
while
we
believe
the
assumptions on
which the
forward-looking statements
are based
are reasonable,
there can
be no
assurance that
these forward-
looking
statements
will
prove
to
be
accurate.
Further,
forward-looking statements
included
herein
are
only
made
as
of
the
respective
dates
thereof,
or
if no
date
is stated,
as of
the date
hereof.
Except
as otherwise
required
by
law,
we
disclaim
any
intent or obligation
to update publicly
these forward-looking statements,
whether because of
new information, future
events, or
otherwise.
GENERAL
Cal-Maine
Foods,
Inc.
is
primarily
engaged
in
the
production,
grading,
packaging,
marketing
and
distribution
of
fresh
shell
eggs. Our operations are fully integrated
under one operating segment.
We are
the largest producer and distributor
of fresh shell
eggs in the United States.
Our total flock of approximately 41.3 layers and 9.6
pullets and breeders is the largest in the U.S. We
sell most
of our
shell eggs
to a
diverse
group of
customers, including
national and
regional grocery
store chains,
club stores,
companies
servicing
independent
supermarkets
in
the
U.S.,
food
service
distributors,
and
egg
product
consumers
in
states
across the southwestern, southeastern, mid-western and mid
-Atlantic regions of the United States.
Our
operating
results
are
materially
impacted
by
market
prices for
eggs
and
feed
grains
(corn
and
soybean
meal),
which
are
highly
volatile,
independent
of
each
other,
and
out
of
our
control.
Generally
speaking,
higher
market
prices
for
eggs
have
a
positive
impact
on
our
financial
results
while
higher
market
prices
for
feed
grains
have
a
negative
impact
on
our
financial
results. Although we
use a variety of
pricing mechanisms in pricing
agreements with our customers,
we sell the majority
of our
conventional
shell
eggs
based
on
formulas
that
take
into
account,
in
varying
ways,
independently
quoted
regional
wholesale
market prices for
shell eggs or formulas
related to our
costs of production which
include the cost
of corn and soybean
meal. As
an example
of the volatility
in the market
prices of shell
eggs, the Urner
-Barry Southeastern
Regional Large
Egg Market Price
per dozen eggs
(“UB southeastern
large index”) in
fiscal year 2020
ranged from a
low of $0.62
in July 2019
to a high
of $3.18
in March 2020.
Generally,
we purchase
primary feed
ingredients,
mainly corn
and soybean
meal, at
current market
prices. Corn
and soybean
meal
are
commodities
and
are
subject
to
volatile
price
changes
due
to
weather,
various
supply
and
demand
factors,
transportation and storage costs, speculators, and agricultural, energy
and trade policies in the U.S. and internationally.
Specialty shell
eggs have
been a
significant and
growing portion
of the
market. In
recent years,
a significant
number of
large
restaurant chains, food
service companies and
grocery chains, including
our largest customers,
announced goals to
transition to
an exclusively
cage-free egg
supply chain
by specified
future dates.
Additionally,
several states,
representing 23%
of the
U.S.
Index
21
total population according to the U.S. Census Bureau,
have passed legislation requiring that all eggs
sold in those states must be
cage-free
eggs by
specified
future dates,
and
other states
are
considering
such legislation.
For additional
information, see
the
2020 Annual
Report, Part I,
Item 1, “Business
– Growth
Strategy” and
“– Government
Regulation,” and
the fifth risk
factor in
Part I, Item 1A, “Risk Factors.”
Retail
sales
of
shell
eggs
historically
have
been
highest
during
the
fall
and
winter
months
and
lowest
during
the
summer
months. Prices
for shell
eggs fluctuate
in response
to seasonal
demand factors
and a
natural increase
in egg
production during
the
spring
and
early
summer.
Historically,
shell
egg
prices
tend
to
increase
with
the
start
of
the
school
year
and
tend
to
be
highest
prior
to
holiday
periods,
particularly
Thanksgiving,
Christmas,
and
Easter.
Consequently,
and
all
other
things
being
equal, we would
expect to experience
lower selling prices, sales
volumes and net
income (and may incur
net losses) in our
first
and
fourth
fiscal
quarters
ending
in
August/September
and
May/June,
respectively.
Because
of
the
seasonal
and
quarterly
fluctuations,
comparisons
of
our
sales
and
operating
results
between
different
quarters
within
a
single
fiscal
year
are
not
necessarily meaningful comparisons.
COVID-19
Since early
2020,
the coronavirus
(“COVID-19”) outbreak,
characterized as
a pandemic
by the
World
Health Organization
on
March
11,
2020,
has
caused
significant
disruptions
in
international
and
U.S.
economies
and
markets.
We
understand
the
challenges
and
difficult
economic
environment
facing
the
families
in
the
communities
where
we
live
and
work,
and
we
are
committed to
helping where
we can.
One way
we have
done this
is by providing
food assistance
to those
in need.
Cal-Maine
Foods has donated
approximately 1.5 million
dozen eggs in the
first three
quarters of fiscal 2021.
We
believe we are taking
all
reasonable
precautions
in
the
management
of
our
operations
in
response
to
the
COVID-19
pandemic.
Our
top priority
is
the
health and
safety of
our employees,
who work
hard every
day to
produce eggs
for our
customers. As
part of
the nation’s
food
supply,
we work
in a critical
infrastructure industry,
and believe
we have
a special
responsibility to
maintain our
normal work
schedule. As
such, we
are in
regular communication
with our
managers across
our operations
and continue
to closely
monitor
the situation
in our
facilities and
in the
communities
where we
live and
work.
We
have implemented
procedures designed
to
protect
our
employees,
taking
into
account
guidelines
published
by
the
Centers
for
Disease
Control
and
other
government
health
agencies,
and
we
have
strict
sanitation
protocols
and
biosecurity
measures
in
place
throughout
our
operations
with
restricted
access
to
visitors.
All
non-essential
corporate
travel
has
been
suspended.
There
are
no
known
indications
that
COVID-19 affects hens or can be transferred through the food supply.
We
continue to
proactively monitor
and manage
operations during
the COVID-19 pandemic,
including additional
related costs
that we incurred or
may incur in the future.
In the thirty-nine weeks ended
February 27, 2021,
we spent $1.8
million (excluding
medical insurance
claims) related
to the
pandemic, of
which $397
thousand was
spent in
the third
quarter of
fiscal 2021.
The
majority
of
such
expenses
for
both
periods
were
related
to
additional
labor,
primarily
reflected
in
cost
of
sales.
Medical
insurance
claims
related
to
COVID-19
paid
during
the
thirty-nine
weeks
ended
February
27,
2021
were
an
additional
$1.1
million of which $322 thousand were incurred in the third fiscal quarter of
2021.
EXECUTIVE OVERVIEW
For the
third quarter
of fiscal
2021,
we recorded
a gross
profit of $47.5
million compared
to $49.8
million for
the same period
of fiscal
2020.
Demand for
shell eggs
remained favorable,
primarily at
the retail
level as consumers
continue to
prepare more
meals at
home during
the COVID-19
pandemic.
According to
data provided
by Informational
Resources,
Inc. (“IRI”)
dozens
sold in the Total US -
Multi Outlet channel for conventional eggs for the
calendar year-to-date through March 7, 2021 increased
2.7% and specialty
dozens increased 14.0%
compared to the
same period in
the calendar year.
Our total dozens
sold increased
3.1% to 279.7 million
dozen shell eggs for the
third quarter of fiscal 2021
compared to 271.3 million
dozen for the same period
of fiscal 2020.
This is due to an increase in specialty egg dozens sold of 16.2%.
The
daily
average
price
for
the
UB
southeastern
large
index
for
third
quarter
of
fiscal
2021
increased
4.3%
from
the
same
period
in the
prior
year.
Our net
average
selling price
per dozen
for
the third
quarter
of fiscal
2021 was
$1.246
compared to
$1.236 in the prior
year period.
Although the hen numbers
reported by the United
States Department of Agriculture
(“USDA”)
as of March 1, 2020 were 327.4
million, which represents 3.1 million fewer
hens than reported a year ago.
The USDA reported
that the
hatch
from October
2020 through
February
2021 increased
2.6%
as compared
to the
prior comparable
period, which
may indicate an
increased supply of hens
in the future. As
we emerge from
the COVID-19 pandemic
with an anticipated return
in food
service demand,
these growing
supply indicators
could affect
the overall
balance of
supply and
demand for
shell eggs
and have an impact on market prices.
Our farm
production costs
per dozen
produced for
the third
quarter of
fiscal 2021
increased 7.0%
or $0.051
compared to
third
quarter of
fiscal 2020.
This increase
was primarily
due to higher
feed costs
in the
third quarter of
fiscal 2021
compared to
the
Index
22
same period
in the
prior fiscal
year due
to increased
prices for
corn and
soybeans caused
by increased
export demand,
global
weather
conditions
and
geopolitical
issues.
Other
farm
production
costs
for
the
third
quarter
of
fiscal
2021
decreased
3.1%
compared to the same period in the prior fiscal year due to reductions in
flock amortization and facility expenses.
RESULTS OF
OPERATIONS
The
following
table
sets
forth,
for
the
periods
indicated,
certain
items
from
our
Condensed
Consolidated
Statements
of
Operations expressed as a percentage of net sales.
13 Weeks Ended
39 Weeks Ended
February 27, 2021
February 29, 2020
February 27, 2021
February 29, 2020
Net sales
100.0
%
100.0
%
100.0
%
100.0
%
Cost of sales
86.8
%
85.6
%
87.7
%
93.5
%
Gross profit
13.2
%
14.4
%
12.3
%
6.5
%
Selling, general and administrative
13.3
%
12.8
%
13.6
%
14.7
%
Loss on disposal of fixed assets
0.1
%
0.1
%
—
%
0.1
%
Operating income (loss)
(0.2)
%
1.5
%
(1.3)
%
(8.3)
%
Total other income, net
3.4
%
3.7
%
1.5
%
1.9
%
Income (loss) before income taxes
3.2
%
5.2
%
0.2
%
(6.4)
%
Income tax (benefit) expense
(0.5)
%
1.2
%
(0.4)
%
(1.7)
%
Net income (loss)
3.7
%
4.0
%
0.6
%
(4.7)
%
Less: Income (loss) attributable to
noncontrolling interest
—
%
(*)
%
—
%
(*)
%
Net income (loss) attributable to Cal-Maine
Foods, Inc.
3.7
%
4.0
%
0.6
%
(4.7)
%
(*)
Represents less than
0.1% of Net sales
NET SALES
Net sales
for the
third quarter
of fiscal
2021 were
$359.1 million, an
increase of
$13.5 million, or 3.9%,
compared to
net sales
of $345.6 million
for the same
period of fiscal
2020.
The increase was
primarily due
to a 3.1%
increase in the
total volume of
dozen eggs sold
which accounted for a
$10.5 million increase in
net sales. Dozens sold
for the third quarter
ended February 27,
2021 were 279.7 million compared to 271.3 million for the same period
of fiscal 2020.
Net
shell
egg
sales
of
$350.0 million
and
$336.4 million
made
up
approximately
97.5% and
97.3%
of
net
sales for
the
third
quarters
ended February 27, 2021
and February 29, 2020,
respectively. The
net average selling price per
dozen of shell eggs for
the third quarters ended
February 27, 2021 and
February 29, 2020 was $1.246
and $1.236, respectively.
The increase in selling
price per dozen accounted for a $2.8 million increase in net sales.
Egg products
accounted for
2.5% and
2.7% of
net sales
for the
third quarter
ended February
27, 2021
and February
29, 2020,
respectively.
These
revenues
were
$9.1
million
and
$9.2
million
for
the
third
quarters
of
fiscal
2021
and
2020,
respectively.
The decrease is primarily due to decreased volume partially offset
by higher selling prices.
Net
sales
for
the
thirty-nine
weeks
ended
February
27,
2021
were
$999.2 million,
an
increase
of
$100.9 million,
or 11.2%,
compared to
net sales of
$898.3 million for
the same period
of fiscal 2020
.
The increase was
primarily due
to a 7.0%
increase
in egg selling
prices which
accounted for
a $63.8 million
increase in net
sales. The
net average
selling price per
dozen of shell
eggs for the thirty-nine weeks ended February 27, 2021 and February
29, 2020 was $1.185 and $1.107, respectively.
Net shell
egg sales
of $973.5 million
and $874.1
million made
up approximately
97.4% and 97.3%
of net
sales for
the thirty-
nine
weeks
ended
February
27,
2021
and
February
29,
2020,
respectively.
Dozens
sold
for
the
thirty-nine
weeks
ended
February 27, 2021 were 817.4 million,
a 3.9% increase from 786.7 million for
the same period of fiscal 2020.
The total volume
increase accounted for a $36.3 million increase in net sales.
Egg
products
accounted
for
2.6% and
2.7%
of net
sales for
the thirty
-nine
weeks ended
February
27, 2021
and
February
29,
2020,
respectively.
These
revenues
were
$25.7 million
for
the
thirty-nine
weeks
ended
February
27,
2021,
compared
to
$24.2 million for the same period in fiscal 2020,
primarily due to higher selling prices slightly offset by decreased volume.
Index
23
The table below presents an analysis of our conventional and specialty shell egg
sales (in thousands, except percentage data):
13 Weeks Ended
39 Weeks Ended
February 27, 2021
February 29, 2020
February 27, 2021
February 29, 2020
Total net sales
$
359,080
$
345,588
$
999,189
$
898,276
Conventional
$
203,189
58.0
%
$
210,329
62.5
%
$
560,297
57.5
%
$
518,898
59.4
%
Specialty
145,210
41.5
%
125,019
37.2
%
408,537
42.0
%
352,118
40.3
%
Egg sales, net
348,399
99.5
%
335,348
99.7
%
968,834
99.5
%
871,016
99.7
%
Other
1,583
0.5
%
1,028
0.3
%
4,619
0.5
%
3,050
0.3
%
Net shell egg sales
$
349,982
100.0
%
$
336,376
100.0
%
$
973,453
100.0
%
$
874,066
100.0
%
Net shell egg sales as a
percent of total net sales
97.5
%
97.3
%
97.4
%
97.3
%
Dozens sold:
Conventional
203,070
72.6
%
205,307
75.7
%
599,625
73.4
%
599,788
76.2
%
Specialty
76,645
27.4
%
65,970
24.3
%
217,735
26.6
%
186,939
23.8
%
Total dozens sold
279,715
100.0
%
271,277
100.0
%
817,360
100.0
%
786,727
100.0
%
Net average selling price per
dozen:
Conventional
$
1.001
$
1.024
$
0.934
$
0.865
Specialty
$
1.895
$
1.895
$
1.876
$
1.884
All shell eggs
$
1.246
$
1.236
$
1.185
$
1.107
Conventional
shell eggs
include all
shell egg
sales not
specifically identified
as specialty
shell egg
sales. Comparing
the third
quarters
ended February 27, 2021 and
February 29, 2020,
conventional egg dozens sold
decreased 1.1% and the
average selling
price
per
dozen
decreased
2.2%
to
$1.001
from
$1.024.
Comparing
the
thirty-nine
weeks
ended
February
27,
2021
and
February
29,
2020,
conventional
shell
egg
dozens
sold
remained
relatively
flat
while
the
average
selling
price
per
dozen
increased 8.0%
to $0.934 from $0.865.
Specialty
eggs,
which
include nutritionally
enhanced,
cage-free,
organic
and
brown
eggs, continued
to
make
up
a significant
portion of
our total
shell egg
revenue and
dozens sold. Specialty
egg retail
prices are
less cyclical
than conventional
shell egg
prices and are
generally higher due
to consumer willingness
to pay more
for specialty eggs.
For the third
quarter of fiscal
2021
and
2020,
specialty
shell
egg
dozens
sold
increased
16.2%,
and
the
average
selling
price
per
dozen
remained
the
same
at
$1.895.
For the
thirty-nine
weeks ended
February 27,
2021, specialty
shell egg
dozens sold
increased
16.5% and
the average
selling
price
decreased
0.4%
to
$1.876
from
$1.884
for
the
same
period
of
fiscal
2020.
In
the
third
quarter
of
fiscal
2021,
demand for specialty eggs
increased as consumers
opted for the specialty eggs
which is noted in the
Executive Overview above
along with increased
promotional spending. For
the thirty-nine weeks
ended February 27, 2021,
demand for specialty
eggs was
positively impacted by the higher conventional egg prices as compared
to the same period in the prior year.
The shell
egg sales
classified as
“Other” represent
sales of hard
cooked eggs,
hatching eggs,
and other
miscellaneous products
included with our shell egg operations.
Egg
products
are shell
eggs
that are
broken
and
sold
in liquid,
frozen,
or dried
form.
Our egg
products
are sold
through our
wholly-owned subsidiaries American
Egg Products, LLC
and Texas
Egg Products, LLC. Comparing
the third quarters
of fiscal
2021 and
2020,
pounds
sold decreased
11.3%; however,
the average
selling price
per pound
increased 11.2
%
to $0.584
from
$0.525. Comparing
the thirty-nine
weeks ended
February 27,
2021 and
February 29,
2020, pounds
sold decreased
8.9% while
the average selling price per pound increased 16.7% to $0.553
from $0.474.
COST OF SALES
Cost of sales consists
of costs directly
related to production, processing
and packing of shell
eggs, purchases of
shell eggs from
outside producers,
processing and
packing of
liquid and
frozen egg
products, and
other non-egg
costs.
Farm production
costs
Index
24
are
costs incurred
at
the
egg
production
facility,
including
feed,
facility,
hen
amortization,
and
other
related
farm
production
costs.
The following table presents the key variables affecting cost of
sales (in thousands, except cost per dozen data):
13 Weeks Ended
39 Weeks Ended
February 27, 2021
February 29, 2020
% Change
February 27, 2021
February 29, 2020
% Change
Cost of Sales:
Farm production
$
190,883
$
172,525
10.6
%
$
531,877
$
499,840
6.4
%
Processing,
packaging, and
warehouse
63,640
60,186
5.7
187,014
170,998
9.4
Egg purchases and
other (including
change in inventory)
50,443
56,179
(10.2)
137,001
146,754
(6.6)
Total shell eggs
304,966
288,890
5.6
855,892
817,592
4.7
Egg products
6,597
6,870
(4.0)
20,565
19,687
4.5
Other
—
—
—
—
2,919
(100.0)
Total
$
311,563
$
295,760
5.3
%
$
876,457
$
840,198
4.3
%
Farm production costs
(per dozen produced)
Feed
$
0.467
$
0.406
15.0
%
$
0.422
$
0.411
2.7
%
Other
$
0.313
$
0.323
(3.1)
%
$
0.318
$
0.328
(3.0)
%
Total
$
0.780
$
0.729
7.0
%
$
0.740
$
0.739
0.1
%
Outside egg purchases
(average cost per
dozen)
$
1.26
$
1.17
7.7
%
$
1.23
$
1.12
9.8
%
Dozens produced
248,130
239,072
3.8
%
731,205
684,837
6.8
%
Dozens sold
279,715
271,277
3.1
%
817,360
786,727
3.9
%
Cost of sales for
the third quarter of
fiscal 2021 was $311.6
million, an increase of
$15.8 million, or 5.3%,
from $295.8 million
for the
same period
of fiscal
2020. The
increase was
primarily driven
by the
increase in
farm production
costs and
processing
costs.
Farm production
costs were primarily
impacted by higher
feed costs
of $0.467
per dozen
produced compared
to $0.406
per dozen
produced for
the same
period in
the prior
year.
Other farm
production costs
per dozen
produced decreased
3.1% to
$0.313
for
the
quarter
ended
February
27,
2021,
compared
to
$0.323
for
the
same
period
of
last
year,
primarily
from
lower
facility costs
and amortization
expense.
The lower
feed costs in
prior periods
which are
capitalized in
our flocks
during pullet
production helped reduce amortization expense in the third
quarter of fiscal 2021 as compared to the same period in fiscal 2020.
Facility
costs
decreased
in
the
third
quarter
of
fiscal
2021
compared
to
the
same
period
in
fiscal
2020
due
to
improved
efficiencies
in
our
utilization
of
our
facilities
and
increased
volume
of
production.
Processing
costs
increased
due
to
a
3.2%
increase
in
the
volume
of
eggs
processed
compared
to
the
same
period
of
the
prior
year.
The
cost
of
packaging
materials
increased 2.0%
compared to
the prior
year period
as the
retail channel
demand increased
due to
the pandemic.
The pandemic
led to
an increase
in labor
costs. Dozens
produced increased
3.8% compared
to the
same period
of fiscal
2020.
Egg purchase
expenses decreased 10.2%,
primarily due to the
decrease in the volume
of outside egg purchases,
partially offset by
an increase
in the cost of these purchases.
Cost of sales for the thirty-nine weeks ended February
27, 2021 was $876.5 million, an increase of $36.3 million,
or 4.3%, from
$840.2 million
for the
same period
of fiscal
2020.
The increase
was primarily
driven by
the increase
in farm
production costs
and processing costs.
Processing costs increased due
to a 5.5% increase in
the volume of eggs processed
compared to the same
period of the prior year.
The cost of packaging materials
increased 2.8%
compared to the prior year
period as the retail channel
demand
increased due
to the
pandemic.
The pandemic
led to
an increase
in labor
costs. Farm
production
costs for
the thirty-
nine weeks
ended February
27, 2021
increased $32.0
million, which
was primarily
due to an
increase in production
volume of
6.8%
compared to the
same period of
fiscal 2020.
Feed cost per
dozen for the
thirty-nine weeks ended
February 27, 2021
was
$0.422,
compared to
$0.411
per dozen
for the
comparable period
of fiscal
2020,
an increase
of 2.7%.
Other farm
production
costs per dozen produced
decreased 3.0% to $0.318
for the thirty-nine weeks
ended February 27, 2021
,
compared to $0.328 for
Index
25
the same period
of last year,
primarily from lower
amortization and facility
expense.
In the prior
fiscal year we
incurred higher
amortization expense due
to selling flocks
early in fiscal
2020 in response
to market conditions.
Facility costs decreased
due to
improved
efficiencies
in
our
utilization
of
our
facilities
and
increased
volume
of
our
production.
Egg
purchase
expenses
decreased 6.6%, primarily
due to the decrease in the
volume of outside egg
purchases, partially offset
by an increase in the
cost
of these purchases.
Included
in
cost
of
sales
for
the
thirty-nine
weeks
ended
February
29,
2020
is
a
$2.9
million
impairment
charge
related
to
decommissioning
older,
less
efficient
production
facilities
as
we
invest
in
new
facilities
to
meet
the
increasing
demand
for
specialty eggs and reduce production costs.
Feed costs started trending higher
midway through the second quarter of
fiscal 2021.
For the third quarter, the
average Chicago
Board of Trade
(“CBOT”) daily market price was $4.97
per bushel for corn and $422.61
per ton for soybean meal,
representing
an increase
of 29.9%
and
42.4%, respectively,
compared
to the
daily average
CBOT prices
for
the same
period
last year.
As
feed
ingredient
prices
rose
through
the
second
and
third
quarters
of
fiscal
2021,
we
benefited
from
our
normal
operating
practices of filling our
storage bins at harvest
and locking in the basis
portion of our grain
purchases several months
in advance
to
help
ensure
availability
of feed
ingredients.
Most
of
this benefit
has
been
realized
in
our
second
and
third
fiscal
quarters,
however,
during our
fourth fiscal
quarter we
will be
exposed more
directly to
price movements
in the
feed ingredient
market.
We
expect to
see continued
price volatility
for the remainder
of fiscal
2021 as
increased export
demand for
both soybeans
and
corn
is
placing
pressure
on
domestic
supplies
and
carryout
inventories
are
projected
to
be
lower.
Additionally,
the
ongoing
uncertainties and
supply chain
disruptions related
to the
COVID-19 outbreak,
weather fluctuations
and geopolitical
issues will
continue to affect market prices for our primary feed ingredients.
GROSS PROFIT
Gross profit for the
third quarter of fiscal 2021
was $47.5 million compared to
$49.8 million for the
same period of fiscal 2020.
The decrease
of $2.3
million was
primarily
due to
increased farm
production cost
and processing
costs, partially
offset
by an
increase in dozens sold for specialty eggs.
For
the
thirty-nine
weeks
ended
February
27,
2021
gross
profit
was
$122.7
million
compared
to
$58.1
million
for
the
same
period of
fiscal 2020.
The increase
of $64.7
million was
primarily due
to the
increase in
conventional
shell egg
selling prices
and an increase in dozens sold for specialty eggs.
SELLING, GENERAL, AND ADMINISTRATIVE
EXPENSES
Selling,
general,
and
administrative
(“SGA”)
expenses
include
costs
of
marketing,
distribution,
accounting,
and
corporate
overhead.
The following table presents an analysis of our SGA expenses (in thousands):
13 Weeks Ended
February 27, 2021
February 29, 2020
$ Change
% Change
Specialty egg expense
$
16,162
$
12,581
$
3,581
28.5
%
Delivery expense
13,359
13,309
50
0.4
%
Payroll, taxes and benefits
10,195
10,639
(444)
(4.2)
%
Stock compensation expense
964
886
78
8.8
%
Other expenses
6,976
6,816
160
2.3
%
Total
$
47,656
$
44,231
$
3,425
7.7
%
For the
third quarter
of fiscal
2021,
SGA expenses
increased 7.7%
to $47.7
million from
$44.2 million
for the
same period
in
fiscal 2020.
Specialty egg expense
increased $3.6 million,
or 28.5%, compared
to the same
period of the
prior year.
Specialty
egg expense,
which includes
franchise fees
and advertising expense,
typically fluctuates
with specialty
egg dozens
sold, which
increased 16.2% for the third quarter ended February 27, 2021.
Index
26
39 Weeks Ended
February 27, 2021
February 29, 2020
$ Change
% Change
Specialty egg expense
$
42,898
$
35,995
$
6,903
19.2
%
Delivery expense
38,905
39,341
(436)
(1.1)
%
Payroll, taxes and benefits
31,526
31,391
135
0.4
%
Stock compensation expense
2,789
2,680
109
4.1
%
Other expenses
19,376
23,027
(3,651)
(15.9)
%
Total
$
135,494
$
132,434
$
3,060
2.3
%
For the thirty-nine weeks
ended February 27, 2021,
SGA expense increased 2.3% to
$135.5 million from $132.4
million for the
same period
in fiscal
2020.
Specialty egg
expense increased
$6.9 million,
or 19.2%,
compared to
the same
period of
the prior
year.
Specialty
egg
expense
typically
fluctuates
with
specialty
egg
dozens
sold,
which
increased
16.5%
for
the
thirty-nine
weeks ended
February 27,
2021. Other
expenses decreased
$3.7
million or
15.9% compared
to the
same period
in fiscal
2020.
This decrease is primarily due to the legal settlement paid in the second
quarter of fiscal 2020 and the first quarter of fiscal 2021
return
of
brokerage
commissions
on
property
and
casualty
insurance
placements
refunded
after
final
reconciliation
of
all
brokerage service agreements.
Included in Other expenses is
approximately $551 thousand relating
to the secondary public offering
completed in August 2020
by the wife of our late founder and a trust of which his
daughters are beneficiaries. For more information, see
Note 13
– Related
Party Transaction of the Notes to Condensed
Consolidated Financial Statements included in this Quarterly Report.
OPERATING
INCOME (LOSS)
For the
third quarter
of fiscal
2021,
we recorded
an operating
loss of
$493 thousand
compared to
an operating
income of
$5.2
million for the same period of fiscal 2020.
For the
thirty-nine weeks
ended February
27, 2021,
we recorded
an operating
loss of
$13.2 million
compared to
an operating
loss of $74.8 million for the same period of fiscal 2020.
OTHER INCOME (EXPENSE)
Total
other
income
(expense)
consists
of
items
not
directly
charged
or
related
to
operations,
such
as
interest
income
and
expense, royalty income, equity in income or loss of unconsolidated entities,
and patronage income, among other items.
For
the
third
quarter
of
fiscal
2021,
we
earned
$661
thousand
of
interest
income
compared
to
$880
thousand
for
the
same
period of fiscal
2020.
For the thirty-nine
weeks ended February
27, 2021,
we earned $2.4 million
of interest income
compared
to $3.9 million for
the same period of fiscal
2020. The decrease for
both periods resulted from
significantly lower interest rates.
The Company
recorded interest expense
of $70
thousand and $77
thousand for the
third quarters
ended February
27, 2021 and
February
29, 2020
,
respectively.
For the
thirty-nine
weeks ended
February
27, 2021
and February
29,
2020
interest expense
was $205 thousand and $258 thousand, respectively.
Patronage
dividends, which
represent distributions
from our
membership
in Eggland’s
Best, Inc.
were $9.0
million and
$10.1
million
for
the
thirteen
and
thirty-nine
weeks
ended
February
27,
2021
and
February
29,
2020,
respectively.
Patronage
dividends are paid once a year based on the profits of Eggland’s
Best as well as its available cash.
For the
third quarter
of fiscal
2021, equity
income of
unconsolidated entities
was $1.9
million compared
to $1.4
million in
the
prior
year
period.
For
the
thirty-nine
weeks
ended
February
27,
2021,
equity
income
of
unconsolidated
entities
was
$1.9
million compared
to $537
thousand for
the prior
year period.
The increase
for both
periods is
primarily due
to the
increase in
egg selling prices positively impacting the profitability of our joint
ventures.
Other,
net for
the third
quarter ended
February 27,
2021, was
income of
$537 thousand
compared to
income of
$79 thousand
for the same period of fiscal 2020.
Other, net
for the
thirty-nine weeks
ended February
27, 2021,
was income of
$1.5 million
compared to
income of $1.9
million
for
the
same
period
of
fiscal
2020.
The
decrease
is
primarily
driven
by
lower
realized
and
unrealized
gains
in
investment
securities available-for-sale.
Index
27
INCOME TAXES
On
March
27,
2020,
the
Coronavirus
Aid,
Relief,
and
Economic
Security
Act
(the
“CARES
Act”)
was
enacted.
The
most
significant provision
of the
CARES Act that
materially affected
the Company’s
income taxes
included the
five-year carryback
allowance for taxable net operating losses generated in the tax years
2018 through 2020, our fiscal years 2019 through 2021.
The Company
is electing
to utilize
that provision,
which will
provide additional
liquidity in
the form
of an
income tax
refund
currently
estimated
to
be
approximately
$14.6
million.
We
anticipate
we
will
receive
the
refund
during
fiscal
year
2022.
Additionally, we recorded
an income tax benefit of approximately $5.0 million related to the carryback
provision.
For the third quarter of fiscal 2021, pre-tax
income was $11.8 million compared to
pre-tax income of $18.0 million for the same
period of fiscal 2020.
We recorded
an income tax benefit of $1.7 million
for the third quarter of fiscal 2021, which
includes the
discrete tax
benefit
of $5.0
million described
above.
Excluding the
tax benefit,
income tax
expense
was $2.9
million for
the
third
quarter
of
fiscal
2021
with
an
adjusted
effective
tax
rate
of
24.6%.
Income
tax
expense
was
$4.3
million
for
the
comparable period of fiscal 2020, which reflects an effective
tax rate of 23.7%.
For the thirty-nine
weeks ended February
27, 2021, pre-tax
income was $2.2
million compared
to pre-tax loss
of $57.5 million
for the same period of fiscal 2020. We
recorded an income tax benefit of $4.1 million,
which includes the discrete tax benefit of
$5.0 million
described above.
Excluding the
tax benefit,
income tax
expense of
$543 thousand
was recorded
with an
adjusted
effective tax
rate of 24.3%.
Income tax benefit
of $15.4
million was
recorded for
the comparable period
of fiscal
2020, which
reflects an effective tax rate of 26.7%.
At February 27,
2021, trade and other
receivables included income
taxes receivables of
$23.6 million compared
to $9.9 million
at May 30, 2020.
Our effective tax
rate differs from
the federal statutory income
tax rate due to
state income taxes, certain
federal tax credits and
certain
items
included
in
income
for
financial
reporting
purposes
that
are
not
included
in
taxable
income
for
income
tax
purposes,
including
tax
exempt
interest
income,
certain
nondeductible
expenses
and
net
income
or
loss
attributable
to
noncontrolling interest.
Results for the current
quarter were favorably
impacted by a $5.0 million
discrete tax benefit related
to
the
CARES
Act,
as
discussed
above
and
in
Note
11
–
Income
Taxes
of
the
Notes
to
Condensed
Consolidated
Financial
Statements in this Quarterly Report.
NET INCOME (LOSS) ATTRIBUTABLE
TO CAL-MAINE FOODS, INC.
Net income for
the third quarter
ended February 27,
2021 was $13.5
million, or $0.28
per basic and
diluted share, compared
to
net income of $13.7
million or $0.28 per basic and diluted share for the same period of fiscal 2020.
Net income for the thirty-nine
weeks ended February 27, 2021
was $6.3 million, or $0.13 per basic
and diluted share, compared
to a net loss of $42.1 million or $0.87 per basic and diluted share for the same period
of fiscal 2020.
Index
28
CAPITAL RESOURCES
AND LIQUIDITY
Our working capital
at February 27,
2021 was $422.0 million,
compared to $429.1
million at May 30,
2020. The calculation
of
working capital
is defined
as current
assets less
current liabilities.
Our current
ratio was
5.19 at
February 27,
2021, compared
with 5.60 at May 30, 2020.
We
had
no
long-term
debt
outstanding
at
February
27,
2021
or
May
30,
2020.
On
July
10,
2018,
we
entered
into
a $100.0
million Senior Secured Revolving
Credit Facility (the “Revolving Credit
Facility”).
As of February 27, 2021,
no amounts were
borrowed under
the Revolving
Credit Facility.
We
have $4.1
million in outstanding
standby letters
of credit,
issued under our
Revolving Credit
Facility for
the benefit
of certain
insurance companies.
Refer to
Note 10
of our
audited financial
statements
included in our 2020 Annual Report for further information regarding
our long-term debt.
For the thirty-nine weeks
ended February 27, 2021
,
$14.7 million in net cash
was provided by operating
activities, compared to
$36.4 million
used in
operating activities
for the
comparable period
in fiscal
2020. This
is primarily
due to
an increase
in egg
selling prices compared to the prior year period.
We
continue
to
invest
in
our
facilities
with
$73.8
million
used
to
purchase
property,
plant
and
equipment
for
the
thirty-nine
weeks
ended
February
27,
2021
compared
to
$94.6
million
in
the
same
period
of
fiscal
2020.
Sales
and
maturities
of
investment
securities,
net
of
purchases,
were
$25.8
million
for
the
thirty-nine
weeks
ended
February
27,
2021
compared
to
$169.4 million
for the comparable
period in fiscal
2020.
We
received $5.8 million
in distributions from
unconsolidated entities
during the first three quarters
of fiscal 2021 compared to
$6.1 million for the same peri
od fiscal of 2020.
During the thirty-nine
weeks ended February 29, 2020, we used $44.5
million in cash in connection with our purchase of certain
assets of Mahard Egg
Farm.
We
used $153
thousand for
principal payments
on finance
leases in
the first
three quarters
of fiscal
2021 compared
to
$1.6 million for principal payments on long-term debt and finance
leases for the same period of fiscal 2020.
As of
February 27,
2021,
cash decreased
$25.2 million
since May
30, 2020
compared to
a decrease
of $1.5
million during
the
same period of fiscal 2020.
We
continue to
take aggressive
steps to
position Cal-Maine
Foods to
meet the
expected future
demand for
cage-free eggs.
We
have
invested
approximately
$418
million
in
facilities,
equipment
and
related
operations
to
expand
our
cage-free
production
starting with
our first
facility in
2008. The
following table
presents material
construction projects
approved as
of February
27,
2021 (in thousands):
Project(s) Type
Projected
Completion
Projected Cost
Spent as of
February 27, 2021
Remaining
Projected Cost
Convertible/Cage-Free Layer Houses & Pullet
Houses
Fiscal 2021
$
46,950
$
10,337
$
36,613
Cage-Free Layer & Pullet Houses/Processing
Facility
Fiscal 2022
94,632
79,558
15,074
$
141,582
$
89,895
$
51,687
We
believe our current
cash balances, investments,
cash flows from operations,
and Revolving Credit Facility
will be sufficient
to fund our current and projected capital needs for at least the next twelve months.
RECENTLY
ISSUED/ADOPTED ACCOUNTING STANDARDS
For
information
on
changes
in
accounting
principles
and
new
accounting
policies,
see
Note
1
-
Summary
of
Significant
Accounting Policies
of the Notes to Condensed Consolidated Financial Statements included in this Quarterly
Report.
CRITICAL ACCOUNTING ESTIMATES
Critical accounting
estimates
are those
estimates
made
in accordance
with U.S.
generally
accepted
accounting
principles that
involve
a
significant
level
of
estimation
uncertainty
and
have
had
or
are
reasonably
likely
to
have
a
material
impact
on
our
financial condition
or results
of operations.
There have
been no
changes to
our critical
accounting estimates
identified in
our
2020 Annual Report.
Index
29
ITEM 4.
CONTROLS
AND
PROCEDURES
Disclosure Controls and Procedures
Our disclosure
controls and
procedures are
designed to
provide reasonable
assurance that
information required
to be
disclosed
by us in the reports
we file or submit
under the Exchange Act
is recorded, processed, summarized
and reported, within the
time
periods
specified in
the Securities
and
Exchange
Commission’s
rules and
forms.
Disclosure controls
and procedures
include,
without limitation, controls and
procedures designed to ensure that
information required to be disclosed
by us in the reports that
we file or
submit under the
Exchange Act is accumulated
and communicated to
management, including our
principal executive
and
principal
financial
officers,
or
persons
performing
similar
functions,
as
appropriate
to
allow
timely
decisions
regarding
required disclosure. Based on an evaluation of our disclosure
controls and procedures conducted by our Chief Executive Officer
and
Chief
Financial
Officer,
together
with
other
financial
officers,
such
officers
concluded
that
our
disclosure
controls
and
procedures were effective as of February 27, 2021 at the reasonable
assurance level.
Changes in Internal Control Over Financial Reporting
There was
no change
in our
internal control
over financial
reporting that
occurred during
the quarter
ended February
27, 2021
that has materially affected, or is reasonably likely to materially affect,
our internal control over financial reporting.
ITEM 1A.
RISK
FACTORS
Except
as
set
forth
below,
there
have
been
no
material
changes
in
the
risk
factors
previously
disclosed
in
the
2020
Annual
Report.
We
are controlled
by the
family of
our late
founder,
Fred R.
Adams, Jr.,
and Adolphus
B. Baker,
our Chief
Executive
Officer and Chairman of our Board of Directors controls
the vote of 100% of our outstanding Class A Common Stock.
Fred R. Adams,
Jr., our
Founder and Chairman Emeritus
died on March 29,
2020. Mr.
Adams’ son-in-law,
Adolphus B. Baker,
our
Chief
Executive
Officer
and
Chairman
of
our
board
of
directors,
Mr.
Baker’s
spouse
and
her
three
sisters
(who
are
Mr.
Adams’
four
daughters)
beneficially
own,
directly
or
indirectly
through
related
entities,
100%
of
our
outstanding
Class
A
Common Stock,
controlling approximately
52.2% of
our total
voting power.
Additionally,
such persons
and Jean
Reed Adams
(“Mrs.
Adams”),
the
wife
of
our
late
founder,
Fred
R.
Adams,
Jr.,
also
have
additional
voting
power
due
to
beneficial
ownership
of
our
Common
Stock,
directly
or
indirectly
through
related
entities,
resulting
in
family
voting
control
of
approximately
57.7%
of
our
total
voting
power.
Mr.
Baker
controls
the
vote
of
100%
of
our
outstanding
Class
A
Common
Stock.
We
understand that the
Adams and Baker
families intend to
retain ownership of
a sufficient amount
of our Common
Stock and
our Class A
Common Stock
to assure continued
ownership of
more than 50%
of the voting
power of our
outstanding shares of
capital stock.
As a
result of
this ownership,
the Adams
and Baker
families have
the ability
to exert
substantial influence
over
matters requiring action by
our stockholders, including amendments
to our certificate of incorporation
and by-laws, the election
and
removal
of
directors,
and
any
merger,
consolidation,
or
sale
of
all
or
substantially
all
of
our
assets,
or
other
corporate
transactions. Delaware
law provides
that the
holders of
a majority
of the
voting power
of shares
entitled to
vote must
approve
certain fundamental
corporate transactions such
as a merger,
consolidation and
sale of all
or substantially
all of a
corporation’s
assets; accordingly,
such a transaction
involving us and
requiring stockholder approval
cannot be effected
without the approval
of
the
Adams
and
Baker
families.
Such
ownership
will
make
an
unsolicited
acquisition
of
our
Company
more
difficult
and
discourage
certain
types
of
transactions
involving
a
change
of
control
of
our
Company,
including
transactions
in
which
the
holders of our
Common Stock might
otherwise receive a
premium for their
shares over then
current market prices.
The Adams
and Baker families’ controlling ownership of our capital stock may
adversely affect the market price of our Common Stock.
The
price
of
our
Common
Stock
may
be
affected
by
the
availability
of
shares
for
sale
in
the
market,
and
you
may
experience
significant
dilution
as
a
result
of
future
issuances
of
our
securities,
which
could
materially
and
adversely
affect the market price of our Common Stock.
The sale
or availability
for sale
of substantial
amounts of
our Common
Stock could
adversely impact
its price.
Our articles
of
incorporation
authorize
us to
issue 120,000,000
shares of
our Common
Stock.
As of
March
29,
2021,
there
were 44,056,163
shares of
our Common
Stock outstanding.
Accordingly,
a substantial
number of
shares of
our Common
Stock are
outstanding
and
are, or
could become,
available for
sale in
the market.
In addition,
we may
be obligated
to issue
additional shares
of our
Common Stock in connection with employee benefit plans (including
equity incentive plans).
Index
30
In the
future, we
may decide
to raise
capital through
offerings of
our Common
Stock, additional
securities convertible
into or
exchangeable for
Common Stock, or
rights to acquire
these securities or
our Common Stock.
The issuance of
additional shares
of our
Common Stock
or additional
securities convertible
into or
exchangeable for
our Common
Stock could
result in
dilution
of existing
stockholders’ equity
interests in
us. Issuances
of substantial
amounts of
our Common
Stock, or
the perception
that
such issuances
could occur,
may
adversely affect
prevailing
market prices
for our
Common Stock,
and we
cannot predict
the
effect this dilution may have on the price of our Common
Stock.
As described in
Note 13
– Related Party
Transaction of
the Notes to Condensed
Consolidated Financial
Statements included
in
this Quarterly
Report,
in August
2020
Mrs. Adams
and the
Daughters’
Trust
(of
which
the daughters
of our
late founder
are
beneficiaries)
sold
6.9
million
shares
of
Common
Stock
in
a
secondary
public
offering
pursuant
to
a
previously
disclosed
Agreement
Regarding
Common
Stock
(the
“Agreement”)
filed
as
an
exhibit
to
our
2020
Annual
Report.
After
the
sale,
approximately
5.0 million
shares (the
“Subject Shares”)
remain registered
under a
shelf registration
statement and
prospectus
dated October 9, 2018 for
potential resale, which shares are subject
to the Agreement. The Agreement
generally provides that if
a holder of Subject
Shares intends to sell any
of the Subject Shares,
such party must give
the Company a right
of first refusal to
purchase all or any of such
shares. The price payable by the Company
to purchase shares pursuant to the exercise
of the right of
first refusal
will reflect
a 6% discount
to the
then-current market
price based
on the 20
business-day volume
weighted average
price. If
the Company
does not
exercise its
right of
first refusal
and purchase
the shares offered,
such party
will, subject
to the
approval of a special committee of independent directors of the Board
of Directors, be permitted to sell the shares not purchased
by the
Company pursuant
to a
Company registration
statement, Rule
144 under
the Securities
Act of
1933, or
another manner
of
sale
agreed
to
by
the
Company.
Although
pursuant
to
the
Agreement
the
Company
will
have
a
right
of
first
refusal
to
purchase all or any of
those shares, the Company may
elect not to exercise its rights
of first refusal, and if so
such shares would
be eligible for sale pursuant to the registration rights in the Agreement or pursuant
to Rule 144 under the Securities Act of 1933.
Sales, or the availability for
sale, of a large number
of shares of our Common
Stock could result in a decline
in the market price
of our Common Stock.
PART
II. OTHER INFORMATION
ITEM 1.
LEGAL PROCEEDINGS
Refer
to
the
discussion
of
certain
legal
proceedings
involving
the
Company
and/or
its
subsidiaries
in
(i)
our
2020
Annual
Report,
Part I
Item 3:
Legal Proceedings,
and
Part II
Item 8,
Notes to
Consolidated
Financial
Statements and
Supplementary
Data, Note 18: Commitments
and Contingencies, and
(ii) in this Quarterly
Report in
Note 12
: Commitments and
Contingencies
of the Notes to Condensed Consolidated Financial Statements, which discussions are incorporated
herein by reference.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF
PROCEEDS
The following table is a summary of our third quarter 2021 share repurchases:
Total
Number of
Maximum Number
Shares Purchased
of Shares that
Total
Number
Average
as Part of Publicly
May Yet
Be
of Shares
Price Paid
Announced Plans
Purchased Under the
Period
Purchased (1)
per Share
Or Programs
Plans or Programs
11/29/20 to 12/26/20
—
$
—
—
—
12/27/20 to 01/23/21
—
—
—
—
01/24/21 to 02/27/21
22,628
36.47
—
—
22,628
$
36.47
—
—
(1)
As permitted under our Amended and Restated 2012 Omnibus Long
-
term Incentive Plan,
these shares were withheld
by us to satisfy tax withholding obligations for employees in connection with
the vesting of restricted common stock.
Index
31
ITEM 6. EXHIBITS
Exhibits
No.
Description
3.1
Second Amended and Restated Certificate of Incorporation of the Registrant
(incorporated by reference to
Exhibit 3.1 in the Registrant’s Form
8-K, filed July 20, 2018)
3.2
Composite Bylaws of the Company (incorporated by reference to Exhibit
3.2 in the Registrant’s Form 10-Q
for the quarter ended March 2, 2013, filed April 5, 2013)
31.1*
Rule 13a-14(a) Certification of the Chief Executive Officer
31.2*
Rule 13a-14(a) Certification of the Chief Financial Officer
32**
Section 1350 Certification of the Chief Executive Officer
and the Chief Financial Officer
101.SCH*+
Inline XBRL Taxonomy
Extension Schema Document
101.CAL*+
Inline XBRL Taxonomy
Extension Calculation Linkbase Document
101.DEF*+
Inline XBRL Taxonomy
Extension Definition Linkbase Document
101.LAB*+
Inline XBRL Taxonomy
Extension Label Linkbase Document
101.PRE*+
Inline XBRL Taxonomy
Extension Presentation Linkbase Document
104
Cover Page Interactive Data File (formatted as Inline XBRL and contained
in Exhibit 101)
*
Filed herewith as an Exhibit.
**
Furnished herewith as an Exhibit.
+
Submitted electronically with this Quarterly Report.
SIGNATURES
Pursuant to
the requirements
of the Securities
Exchange Act
of 1934,
the registrant has
duly caused
this report
to be signed
on
its behalf by the undersigned, thereunto duly authorized.
CAL-MAINE FOODS, INC.
(Registrant)
Date:
March 29, 2021
/s/ Max P.
Bowman
Max P.
Bowman
Vice President, Chief Financial
Officer
(Principal Financial Officer)
Date:
March 29, 2021
/s/ Michael D. Castleberry
Michael D. Castleberry
Vice President, Controller
(Principal Accounting Officer)